Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2017

Influence of Contextual Factors and Self Efficacy on SelfManagement in Parents of Children with Cystic Fibrosis
Erin B. Booth
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Maternal, Child Health and Neonatal Nursing Commons, and the Pediatric Nursing
Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/5152

This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars
Compass. For more information, please contact libcompass@vcu.edu.

©Erin B. Booth
All Rights Reserved

2017

INFLUENCE OF CONTEXTUAL FACTORS AND SELF EFFICACY ON SELF
MANAGEMENT IN PARENTS OF CHILDREN WITH CYSTIC FIBROSIS

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Nursing at Virginia Commonwealth University

Erin Bishop Booth
East Carolina University, B.S.N
Virginia Commonwealth University, M.S.

Director: Jeanne Salyer, Ph.D., RN
Associate Professor, Adult Health Nursing
School of Nursing

Virginia Commonwealth University
Richmond, Virginia
December, 2017

ii

ACKNOWLEDGMENTS

I would like to express my appreciation to a number of individuals who have helped me
with this project. First and foremost my academic advisor/dissertation chair, Dr. Jeanne Salyer.
Dr. Salyer has been a source of persistent encouragement and guidance throughout coursework
and the dissertation process. Also a special thanks to my other committee members Dr. Suzanne
Ameringer, who stepped up a served as my advisor during coursework and lead me though my
pilot study work. Dr. Edmond Wickham who helped me with survey development for my first
pilot study and provided contributions towards the proposal. Dr. Kathleen Sawin who was
critical in helping identify the theoretical framework used in my project. I would also like to
acknowledge Dr. Lauren Goodloe, although no longer with us, who encouraged me to start this
journey many years ago.
I also want to extend acknowledgment to the clinic staff at the Children’s Hospital of
Richmond’s pulmonary (Cystic Fibrosis) clinic for being so welcoming and helpful during data
collection. Also I would like to extend appreciation to the participants of this study who willing
completed the surveys in hopes to help other families in the future.
I would also like to thank Keith Sledge (and family), founder of Pharmaceutical
Specialties Inc. for giving me the opportunity to work and further my studies with both a flexible
schedule and tuition assistance.
Finally, a special thank you to my supportive husband Jordan, and my children, Jackson
and Ford. You have all been patient during this long process. I could not have done it without
you. This would not have been possible without all of the gentle nudges and the support from all
of my other family and friends.

iii

TABLE OF CONTENTS

Page
LIST OF TABLES ..................................................................................................................... vi
LIST OF FIGURES ................................................................................................................... vii
ABSTRACT ............................................................................................................................. viii
STATEMENT OF THE PROBLEM .......................................................................................... 2
Background and Significance...................................................................................................... 2
Chronic Illness ......................................................................................................................... 3
Self-Management..................................................................................................................... 4
Knowledge ............................................................................................................................... 6
Self-efficacy............................................................................................................................. 7
Theoretical Framework ............................................................................................................... 7
Statement of Purpose................................................................................................................. 10
Summary ................................................................................................................................... 10
A SURVEY OF KNOWLEDGE RELATED TO CYSTIC FIBROSIS RELATED DIABETES
................................................................................................................................................... 11
Abstract .................................................................................................................................. 11
Methods ................................................................................................................................. 14
Results ................................................................................................................................... 16
Conclusion ............................................................................................................................. 18
References ............................................................................................................................. 22
THEORETICAL FRAMEWORK AND METHODS .............................................................. 25
Context................................................................................................................................... 25
Process. .................................................................................................................................. 27
Outcomes. .............................................................................................................................. 28
Instruments and Measures ..................................................................................................... 29

iv

Data Collection ...................................................................................................................... 35
Statistical Analysis ................................................................................................................ 36
Summary................................................................................................................................ 37
INFLUENCE OF CONTEXT AND PROCESS FACTORS ON FAMILY SELF
MANAGEMENT IN CAREGIVERS OF CHILDREN WITH CYSTIC FIBROSIS .............. 38
Abstract .................................................................................................................................. 38
Introduction ........................................................................................................................... 40
Methods ................................................................................................................................. 41
Demographic and Clinical Characteristics of the Sample ..................................................... 42
Context Variables .................................................................................................................. 42
Process Variables ................................................................................................................... 44
Proximal Outcomes ............................................................................................................... 46
Statistical analysis.................................................................................................................. 47
Results ....................................................................................................................................... 47
Sample ................................................................................................................................... 47
Descriptive statistics .............................................................................................................. 48
Group Comparisons ............................................................................................................... 50
Correlation analysis ............................................................................................................... 50
Discussion ................................................................................................................................. 51
Limitations ................................................................................................................................ 56
Summary & Conclusions .......................................................................................................... 56
How Might This Information Affect Nursing Practice ............................................................. 57
References ................................................................................................................................. 63
DISCUSSION OF FINDINGS.................................................................................................. 66
Limitations ............................................................................................................................. 66
Implications for Nursing Practice .......................................................................................... 68
Implications for Nursing Theory and Research ..................................................................... 68
Summary................................................................................................................................ 69
REFERENCES .......................................................................................................................... 70
APPENDIXES .......................................................................................................................... 75
APPENDIX A........................................................................................................................ 76

v

DEMOGRAPHIC QUESTIONAIRE.................................................................................... 76
TREATMENT COMPLEXITY SCORE .............................................................................. 80
APPENDIX C ........................................................................................................................ 82
VISUAL ANALOG SCALE ................................................................................................. 82
APPENDIX D........................................................................................................................ 84
THE PATIENT HEALTH QUESTIONAIRE (PHQ-9) ....................................................... 84
APPENDIX E ........................................................................................................................ 86
PERCEIVED HEALTH COMPETENCE SCALE ............................................................... 86
APPENDIX F ........................................................................................................................ 88
MOUNTIAN WEST CYSTIC FIBROSIS CONSORTIUM QUESTIONNAIRE ............... 88
APPENDIX G...................................................................................................................... 102
CF KNOWLEDGE AND ATTIDTUDES QUESTIONNAIRE ......................................... 102
APPENDIX H...................................................................................................................... 108
SELF MANAGEMENT BEHAVIORS QUESTIONNAIRE ............................................. 108
APPENDIX I ....................................................................................................................... 102
RESEARCH SUBJECT INFORMATION AND CONSENT FORM ................................ 102
VITA ....................................................................................................................................... 109

vi

LIST OF TABLES
Table 1: Manifestations related to Cystic Fibrosis ......................................................................... 3
Table 1: Sample Characteristics ................................................................................................... 24
Table 1: Sample Characteristics of Parent/Caregiver.................................................................. 58
Table 2: Child Characteristics ...................................................................................................... 59
Table 3: Descriptive tatistics of Model Variables for Parent/Caregiver ..................................... 60
Table 4: Group Comparisons between Medicaid and Private Insurance..................................... 61
Table 5: Correlations between Context and Process Variables and Self Management Behaviors
....................................................................................................................................................... 62

vii

LIST OF FIGURES
Figure 1: Individual and Family Self Management Theory............................................................ 9
Figure 2: Individual & Family Self-Management Theory Applied to Family Self-Management of
Children with Cystic Fibrosis ....................................................................................................... 30

viii

ABSTRACT

INFLUENCE OF CONEXTUAL FACTORS AND SELF- EFFICACY ON SELFMANAGEMENT IN PARENTS OF CHILDREN WITH CYSTIC FIBROSIS

A dissertation submitted in partial fulfillment of the requirement for the degree of Doctor of
Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2017

Director: Jeanne Salyer, Ph.D., RN, Associate Professor
School of Nursing, Virginia Commonwealth University

Cystic Fibrosis, a life threatening autosomal recessive genetic disease, is characterized by
a defective gene resulting in the production of thick mucus that obstructs the lungs and pancreas.
CF requires intensive management performed at the home. An initial pilot study was performed
to describe knowledge of CF related diabetes (CFRD) in adults with CF. The findings of this
study, which demonstrated that adults with CF lacked sufficient knowledge about CFRD
confirmed the need to explore additional self-management requirements guided by a theoretical
framework. The second study presented in this dissertation used the Individual and Family SelfManagement Theory (IFSMT) to describe context (condition-specific and individual and family
factors) and process (self-efficacy and knowledge) and outcome (family self-management)
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variables for caregivers of children with CF. It also compared differences in context, process,
and outcomes in caregivers based on socioeconomic status (Medicaid vs. private insurance), and
explored correlations among context, process, and outcomes. Participants for this cross-sectional
descriptive study were caregivers of children with CF who had been diagnosed with CF for at
least 9 months. Participants completed a demographic survey and questionnaires that included
measures of perceived disease severity (VAS), depressive symptoms (Patient Health
Questionnaire), self-efficacy (Perceived Health Competence Scale, Mountain West Cystic
Fibrosis Consortium Questionnaire), knowledge (CF Knowledge and Attitudes Questionnaire),
and self management behaviors (Self-Management Behaviors Questionnaire). Additional
information was retrieved from the child’s medical record and included demographic
information as well as height/weight/BMI, pulmonary function test results, medication profile,
and insurance status.
Participants were primarily female caregivers with high self-efficacy, and average
knowledge. The children with CF had moderate treatment complexity and normal/mild
impairment in lung function. Deficits were noted in caregivers’ reproductive and genetic
knowledge. This study found differences between Medicaid and private insurance groups related
to knowledge. There were significant correlations between disease severity and CF specific selfefficacy and nutritional surveillance as well as general self-efficacy and respiratory surveillance.
These findings confirmed that the IFMST would provide a consistent framework to guide
future studies aimed at identifying factors that influence self-management behaviors of CF in
patients and their caregivers.

Chapter 1
STATEMENT OF THE PROBLEM

Background and Significance
Cystic fibrosis (CF), with a prevalence of 1 in 3500 live births, is the most common life
threatening autosomal recessive genetic disease in the United States. Cystic Fibrosis is
characterized by a defective gene that results in the production of thick, tenacious mucus that
obstructs the lungs and the pancreas. CF is a multisystem disease that primarily affects the
respiratory and gastrointestinal systems (Table 1). Co-morbidities are common among patients
with CF and include gastrointestinal symptoms, nutritional failure, diabetes, bone disorders,
sinus problems, and mental disorders. (Fields, Michel, Butler, Kriss, & Albers, 2006; Moran et
al., 2009; Sawicki, Sellers, & Robinson, 2008).
In the 1950’s, a diagnosis of CF resulted in a life expectancy of only 15 years; however,
with continued advances in medical and nutritional management, the life expectancy has
improved significantly and is now 43 years. Of the approximately 30,000 children and adults in
the United States with CF, more than 50% are over the age of 18 years (Registry Highlights,
CFF, 2016). The improved life expectancy has been achieved by employing complex
management including multiple interventions to both prevent and treat manifestations of CF and
its co-morbities.
Increasing survival rates in CF are, in large part, due to more aggressive management of
the disease. The regimen may include nebulized or oral antibiotics, enzymes or nutritional
supplements, insulin, chest physical therapy and exercise. The majority of CF patients require
care at home. Regardless of the age of the individual with CF, management is rarely a solo task;
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Table 1: Manifestations related to Cystic Fibrosis
Organ
Respiratory

Manifestation
Decreased mucociliary clearance, viscous mucus, airway
inflammation, abnormal mucus traps, bronchiectasis

Nasal Manifestations

Chronic sinus infections, viscous mucus, polyps

Pancreatic

Recurrent pancreatitis, obstructed pancreatic ducts,
malabsorption of vitamins A, D, E, K

Bone

Osteoporosis, low bone mineral density, arthritis

GI

Steatorrhea, meconium ileus, chronic elevation of liver
enzymes, cirrhosis, portal hypertension, delayed gastric
emptying

Reproductive

Men: azoospermia/infertility
Women: reduced fertility

family members including parents, grandparents, siblings, and spouses often play an active role
in assisting with care.
Chronic Illness
Chronic illnesses are typically defined as illnesses with a lengthy duration (longer than 3
months) that usually develop slowly. Common childhood chronic illnesses include asthma,
diabetes, and cystic fibrosis. Childhood chronic illnesses present unique challenges to families
who have to navigate a complicated treatment regimen while balancing other family
responsibilities.
Many chronic diseases, including CF, have significant implications for the psychosocial
well-being of the family (Barlow & Ellard, 2006). Furthermore, the need to manage chronic
3

conditions is increasingly recognized as the responsibility of the individual and family (Ryan &
Sawin, 2009). For example, chronic pediatric respiratory diseases such as CF and asthma require
patients and families to engage in ongoing monitoring and treatment to maintain their health.
Self-Management
Self-management has been defined in various ways in the literature. Richard and Shea
define self-management as the ability of the individual, in conjunction with family, community,
and heath care professionals, to manage symptoms; treatments; lifestyle changes, and
psychosocial, cultural, and spiritual consequences of health conditions (Richard & Shea, 2011).
Self-management requires several general and disease specific skills. Examples include making
decisions, partnering with health care providers, solving problems, managing the impact of the
illness on various aspects of life, and taking action (Lorig & Holman, 2003). Self- management
has been widely studied in chronic diseases such as diabetes, asthma, and heart disease. Selfmanagement is especially important as it relates to chronic disease, where the patient is expected
to be responsible for the day to day care over the length of the illness (Lorig & Holman, 2003).
In CF, the ability to self management is a lifetime task.
The management of CF is more complex than merely compliance with prescribed
therapies; it requires patients and families to monitor symptoms and to modify therapies
appropriately. Therefore, skills related to monitoring, decision-making, communicating, and
coping are necessary to enable patients and families to perform self-management behaviors
(Parcel et al., 1994). Parcel et al. postulated a model relating education variables and medical and
interpersonal self-management variables to measures of health status. They found that
knowledge and self-efficacy are important educational variables to address to enable caretakers
of CF patients to be more effective in performing self-management behaviors. Previous research
4

has demonstrated that individuals with CF are able to perform 30-70% of these self-management
tasks. Patients with CF, however, have more difficulty performing some treatments than others
with the highest percent of self-management behaviors in antibiotics management and the lowest
in physiotherapy behaviors (Abbott, Dodd, & Webb, 1996). Improved survival is in large part
due to adoption of aggressive care guidelines and more frequent monitoring of complications.
This has also lead to an overall increase in the complexity of treatment. With the number of
available effective therapies increasing, patients and families may begin to make choices
between the perceived cost or burden of particular self-management treatment behaviors and the
perceived benefit. It will become increasingly important for caregivers and individuals with CF
to understand the actual benefit of treatment in order to make informed choices.
Because CF is a multi system disease, the treatment regimen is multi faceted. As with any
treatment regimen there are both barriers and facilitators. A study by George defined barriers to
self-management as anything identified by the subjects as decreasing the likelihood they would
follow a prescribed treatment regimen. The most common barrier was treatment burden (length,
frequency, complexity of treatments). Additional barriers included social and work demands,
forgetting, and absence of perceived health benefits, fatigue, and stigmas/embarrassment. This
study also identified facilitators of CF self -management, Facilitators of self management are
defined as patient perception of things to increase likelihood they would follow prescribed
regimen. Several facilitators were identified. The most prevalent facilitator identified by the
participants was the role of the CF Clinic. Participants acknowledged attending CF clinic,
receiving feedback on pulmonary function test (PFT), and interacting with CF team promoted
self- management. Other facilitators identified were support and reminders, presence of
perceived health benefits, ease of completion, habit/routine, and distraction and rewards.

5

Knowledge
The role of accurate disease knowledge as it relates to self-management cannot be
overlooked. Not only is it an important predictor of treatment adherence but it can also impact
patient “buy in” by making the patient more informed and involved in their treatment decisions.
(Balfour et al., 2014; Martin, Williams, Haskard, & Dimatteo, 2005). There are few studies that
address understanding patients or parent’s knowledge of CF, and those that exist address specific
issues (i.e. reproductive, nutrition). A higher level of knowledge has been correlated with better
disease management.(Balfour et al., 2014; Parcel et al., 1994). Because the crux of CF care
hinges on self management and self management hinges on knowledge, it is critical to have a
strong knowledge base. Siklosi el al developed, validated, and implemented a disease knowledge
questionnaire for adult patients with CF. They found that although adult CF patients understood
most aspects of their disease, knowledge deficits did exist. The deficits were primarily related to
genetics and reproduction. They found no signification associations between CF knowledge
scores and socioeconomic factors but did find signification associations between scores and
gender and education attainment. Being female and having higher education attainment were
both independent predictors of higher CF knowledge scores. Balfour et al. indentified
knowledge gaps including misinformation on the use of antibiotics relating to resistance, and
understanding the mechanisms behind airway obstruction. They also identified a gap in
knowledge around how and why airway clearance therapies work.
A 2003 study by McCabe highlighted gaps in dietary knowledge and enzyme application
(McCabe, 1996). Studies have also shown that both males and females lack disease specific
reproductive health knowledge and further identified the is a need for specific sexual and
reproductive education (Gage, 2012). A recent study by Dashiff et al (2013) looked at a group of
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adolescents (15-19 years old) who had been diagnosed with CFRD for at least a year. This
descriptive study aimed to answer questions regarding parents’ and adolescents understanding of
CFRD and its management and parents’ and adolescents’ perceptions of adolescents’ selfmanagement of CF and CFRD. Although there was variation in level of understanding of CFRD
from participant to participant, overall the understanding was rudimentary and inaccurate
(Dashiff, Suzuki-Crumly, Kracke, Britton, & Moreland, 2013). The results of this study suggest
that parent and adolescent education about CFRD needs to be improved and reinforced.
Results of this study coupled with the current literature suggest that knowledge gaps exist in the
both the adult CF as well as in caregivers to children with CF.
Self-efficacy
Self-efficacy beliefs are referred to as one’s beliefs in his or her abilities to perform a
particular behavior effectively and successfully. The concept of SE originated from the social
cognitive theory (Bandura 1989) which suggests that self-efficacy beliefs are largely derived
through one’s personal accomplishment history in a given task. Research on the selfmanagement of other chronic illnesses (diabetes, COPD, asthma) has demonstrated that selfefficacy is a critical determinant of learning and performance of self-management behaviors.
Thus, self efficacy is a critical factor for successfully managing the challenges of a chronic
condition such as CF.
Theoretical Framework
There is limited literature spanning more than 20 years addressing topics such as self
management, knowledge, and self efficacy in the CF population, however this research has either
been atheoretical or was guided by a variety of conceptual/theoretical frameworks making it
difficult to make meaningful connections among variables important for chronic disease
7

management. The middle-range theory of Individual and Family Self-Management (IFSMT)
(Figure 1) provides a theoretical framework to guide research on self or family management of
CF because it suggests that self-management (SM) is a complex dynamic phenomenon
consisting of 3 dimensions: context, process, and outcomes (Ryan & Sawin, 2009). Individual
and family SM includes incorporation of health-related behaviors into an individual or family’s
daily functioning. This theory combines and expands on previous work related to individual SM
and adds a focus on dyads within the family or family unit. Although there are established
relationships among variables in the model, a descriptive theory reveals the substance of a
situation however does not provide structured links showing specific relationships among
components. When individual SM is viewed as a systems theory, a change in one component of
the system leads to changes in the entire system.
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Figure 1: Individual and Family Self Management Theory
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Combining the individual and family perspectives improves our understanding of shifts in
balance and roles as family members often evolve and change. For individuals and families, the
management of chronic health conditions leads to improving health outcomes, enhanced quality
of life and realignment of healthcare expenditures.(Ryan & Sawin, 2009).
Statement of Purpose
The purposes of this study were to: (1) describe condition-specific factors (severity of
child’s condition, complexity of the child’s treatment) and the social environment (SES,
depression) for caregivers of children with CF, (2) describe caregiver self-efficacy, knowledge,
and family self-management behaviors in caregivers of children with CF, (3) compare
differences in context (depression), process (knowledge, self-efficacy) and outcomes (selfmanagement behaviors) in caregivers based on SES (Medicaid vs. private insurance), and (4)
explore correlations among context, process, and outcomes.
Summary
Guided by the Individual and Family Self-Management Theory (Ryan & Sawin, 2009),
the purpose of this study is to examine the effects of context (condition specific factors and
physical and social environment) on outcome (self-management). There are currently no studies
using the IFSMT in CF.
In Chapter 2, we will review a pilot study that explored knowledge, specifically related to
CF related diabetes, in adults with CF. This study helped form the background for the subsequent
study (presented in Chapter 4) by recognizing the need for a theoretical framework, as well as
the need to explore factors in additional to knowledge.
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Chapter 2

A SURVEY OF KNOWLEDGE RELATED TO CYSTIC FIBROSIS RELATED DIABETES

Abstract

Objective: Cystic fibrosis (CF) is the most common life threatening autosomal recessive genetic
disease in the United States. Cystic fibrosis related diabetes (CFRD) is the most common comorbidity of CF, as individuals with CF age, the likelihood of developing diabetes increases.
CFRD leads to decreased lung function, poor nutritional status, and decreased survival rates. The
extent to which individuals with CF know about CFRD is unknown.

Research Design and Methods: A cross sectional descriptive design was used. Adults (>18 yrs)
with CF were recruited during an outpatient CF visit and asked to complete a 15-item CFRD
Knowledge Survey. The survey included 10 items on knowledge of CFRD, 2 items on obtaining
information about CF, and 3 items on experience with diabetes.

Results: Twenty-six individuals participated. Regarding knowledge, 92% had heard of CFRD,
65% knew symptoms of CFRD, and 58% knew how the diagnosis was made. A majority (65%)
reported they seek information related to CF only when necessary. The total knowledge score
was significantly correlated with the experience score (r=0.50, P=0.009), and understanding the
importance of knowing that you have CFRD (r=0.80, P<0.001). The experience score was also
significantly correlated with understanding importance of knowing if you have CFRD
(r=0.60, P=0.001). Understanding the importance of knowing if you have CFRD was
significantly correlated with being diagnosed (r=0.43, P=0.028).
11

Conclusion: As the number of individuals diagnosed with CFRD continues to increase, both
pediatric and adult endocrine nurses need to be educated and equipped to successfully manage
this patient population.
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Cystic fibrosis (CF), with a prevalence of 1 in 3500 live births, is the most common life
threatening autosomal recessive genetic disease in the United States. In the 1950’s, a diagnosis of
CF resulted in a life expectancy of only 15 years; however, with advances in medical and
nutritional management, life expectancy, which is now close to 40 years, has improved
significantly. Of the approximately 30,000 children and adults in the United States with CF ,
more than 50% are over the age of 18 years (1).
Improved life expectancy is a positive outcome; however, it has led to the need to address
previously overlooked long-term complications and co-morbidities. Impaired reproductive
health, bone disease, depression, glucose intolerance, and cystic fibrosis related diabetes (CFRD)
have all become integral to successful management of the aging CF population. CFRD, the focus
of this study, is common and patients are not well informed of the symptoms and effects of this
serious co-morbidity.
CFRD is the most common co-morbidity occurring in CF patients, occurring in
approximately 20% of adolescents and up to 50% of adults (2) . However, prevalence may be
underestimated due to differences in screening protocols as well as lack of routine screenings.
CFRD is primarily a result of insulin deficiency with some element of insulin resistance.
Initially, alterations in glucose tolerance in CFRD are seen in the postprandial period, followed
by a progressive decline in insulin secretion, leading to impaired glucose tolerance (IGT) and
ultimately CFRD. As yet, increased age and the presence of exocrine pancreatic deficiency are
the only predictive indicators for developing glucose intolerance or CFRD (2) . The impact of
CFRD cannot be disregarded. Individuals with CFRD have higher rates of lower lung function
(3) , poor nutritional status (4), and decreased rates of survival (5) compared to individuals with
CF but without CFRD .
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Early diagnosis is critical because clinical deterioration begins 6-24 months prior to
diagnosis. Therefore, it is important for health care providers to be aware of what their patients
and caregivers know about CFRD. Moran et al (2) recommended that patients should be well
informed on the frequency of CFRD and the benefits of treatment as well as be provided
education and psychological support. To date, there is limited published information on what
individuals’ with CF know about CFRD. In order to adequately address educational needs in this
population we must first understand their current knowledge and awareness of CFRD.
The purpose of this pilot study was to evaluate the understanding of CFRD in adults with
CF. Specifically, we aimed to a) describe knowledge and experience of CFRD in adults with CF,
b) examine the relationship between knowledge of CFRD and previous experience or exposure
to diabetes and c) describe the sources by which adults with CF obtain information related to
their CF disease.
Methods
Participants
Participants were recruited through the pulmonary clinic at the Virginia Commonwealth
University Medical Center. The clinic treats approximately 140 patients with CF and
approximately 45% of the patients seen in the clinic are over 18 years old. The gender
breakdown is 51% males, 49% females and ethnicity is similar to what is seen across the United
States with 94% Caucasian and the remaining Hispanic or African American. Inclusion criteria
were age 18 and older and a diagnosis of cystic fibrosis. Exclusion criteria were pregnancy
and/or inability to read or write English. There were 28 participants approached for participation
and all chose to participate.
Procedure
14

The Institutional Review Board approved the study. Recruitment occurred by either the
healthcare provider or the researcher approaching patients at the time of their clinic visit to
determine eligibility and interest in participation. If interested, an information sheet with details
concerning the study was provided and served as the implied consent form. Interested
individuals completed the survey.
Instrument
The CFRD Knowledge survey was initially developed by the researcher and formally
evaluated for content and comprehensiveness by content experts including pulmonary and
endocrinology clinicians. The survey consists of 15 items: 1 item assessing presence of CFRD, 8
items on knowledge of CFRD, 1 item to assess how important participants feel it is to know
about a diagnosis of CFRD, 2 items on how often and where participants seek information on
CF, and 3 items on previous experience with or exposure to individuals with diabetes.
A total score was calculated for knowledge; six of the eight items were used to calculate
the score. To assess if participants were aware of the relationship between CFRD and lung
function and weight, four questions were included, two were distracters (not used in the score)
and two assessed knowledge of these relationships. For all knowledge questions, response
options were either yes or no, with opportunities for participants to provide comments. The
comments were not used in scoring however; the purpose was to glean additional information not
specifically addressed in the questions. A score was generated by totaling the number of yes
responses. The knowledge score could range from 0-6 with higher scores indicating more
knowledge.
A total experience score was calculated from the 3 experience with diabetes items
including experience with high blood sugar, experience with insulin, or a family member with
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diabetes. Experience scores could range from 0 to 3, with a score of one or greater indicating
experience.
Demographics and Disease Related Information
For sample description, participants were asked to provide age, gender, ethnicity, race,
highest grade completed, employment status, marital status, how long they had been diagnosed
with CF, and if they had ever been treated at another CF center.
Statistical Analysis
Demographic information was summarized with means (SD) or frequencies and
percentiles. For aim 1, descriptive statistics were used to describe knowledge of CFRD. For aim
2 descriptive statistics were also used to describe the frequency and sources that adults with CF
obtain information about their disease. For aim 3 Pearson correlations were calculated between
total knowledge score and experience score, knowledge and experience scores and understanding
the importance of knowing that you have CFRD. Analysis was performed using SPSS version
19.
Results
Sample Description
The mean age of the participants was 28.1 years (SD= 10.22; range =18-54). The
majority were male (70%) and non-Hispanic or Latino (96%). Thirty-three percent had been
previously diagnosed with CFRD. Table 1 includes additional sample characteristics.
Knowledge and Experience
The majority of participants (92%) had heard of CFRD, however only 62% knew they
were at risk for developing it. When asked if they knew how the diagnosis of CFRD was made,
58% stated yes. Common responses when asked to explain how the diagnosis was made
16

included: blood sugar checks, glucose tolerance test, and Hemoglobin A1C.When asked if they
knew the symptoms of CFRD, only 65% of participants responded yes. The symptoms that were
most frequently identified were increased thirst, increased urination, weight loss or inability to
gain weight and dizziness.
The average knowledge score among all participants was 3.85 however, when broken
into subgroups (diagnosed with CFRD and not being having CFRD) average knowledge score of
the non CFRD group was 3.28 versus an average score of 5 for those that have CFRD.
Only 35% of participants stated that CFRD was related to lung function and 69%
acknowledged the relationship to weight. When asked how important it was to know if they have
CFRD, most (86%) participants felt it was either essential or very important. The majority of
participants (70%) indicated previous experience with diabetes. The majority (70%) of
participants had some experience or exposure to diabetes, and more than half (54%) had been
told they had high blood sugar in the past. Thirty-eight percent of participants had previously
been on insulin and 42% had members of their family with diabetes.
Knowledge was significantly correlated with experience (r = 0.50, p = 0.009), such that
more knowledge about CFRD was associated with more experience. Knowledge was also
significantly correlated with understanding the importance of knowing you have CFRD (r=0.80,
p <0.001). Higher knowledge was related to a greater value being placed on understanding the
importance of knowing you have CFRD. Experience was significantly correlated with
understating the importance of knowing if you have CFRD (r=0.60, p=0.001). Understanding the
importance of knowing if you have CFRD was significantly correlated with being diagnosed
with CFRD (r=0.43, p=0.028).
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Information
We were also interested in knowing how often, from whom, and where participants seek
information about their disease. The majority (63%) reported they seek information when they
need it, 19% seek information monthly, 11% seek weekly, and 7% stated they never seek
information. Doctors were the most common source of information (77%), followed by internet
(69%), and clinic (62%). Participants were able to list additional sources and the top two sources
included two websites: the Cystic Fibrosis Foundation (www.cff.org) and Patients Like Me
(www.patientslikeme.org).
Conclusion
As medical advancements and life expectancy have improved, many children with CF are
living well into adulthood. Questions regarding age, long-term complication and co-morbities
have become more relevant but are not yet fully understood. CFRD represents a gap in diseasespecific knowledge. This study represents the first attempt to understanding what patients know
and understand about CFRD.
Knowledge and Experience
There is limited literature that addresses disease specific knowledge in the CF population.
A 1996 study by McCabe (6)highlighted gaps in dietary knowledge and enzyme application.
Studies have also shown that both males and females lack disease specific reproductive health
knowledge and further identified the is a need for specific sexual and reproductive education (79) . A recent study by Dashiff et al (10) looked at a group of adolescents (15-19 years old) who
had been diagnosed with CFRD for at least a year. This descriptive study aimed to answer
questions regarding parents’ and adolescents understanding of CFRD and its management and
parents’ and adolescents’ perceptions of adolescents’ self-management of CF and CFRD. To
18

assess both the adolescents and parents’ understanding of CFRD, participants were asked, “if
you were talking with a friend, what would you tell them CFRD is?” The findings demonstrated
limited understanding of CFRD by both parents and adolescents ranging from inability to explain
basics of CFRD, to inaccurate explanations of the disease often based on inappropriate
generalizations to other types of diabetes. Although there was variation in level of understanding
of CFRD from participant to participant, overall the understanding was rudimentary and
inaccurate . The results of this study suggest that parent and adolescent education about CFRD
needs to be improved and reinforced (10).
Siklosi el al (11) recognized the need to develop and validate a tool that would
investigate general knowledge in the adult CF population. The results demonstrated that
although adult CF patients understand most aspects of their disease, knowledge deficits did exist.
The deficits were greater related to genetics and reproduction. They found no signification
associations between CF knowledge scores and demographics, socioeconomic factors, clinical
details but did find signification associations between scores and gender and education
attainment. Being female and having higher education attainment were both independent
predictors of higher CF knowledge scores.
This study adds to the currently literature highlighting a gap in CFRD knowledge. Since
this study only included participants who had been diagnosed with CFRD , it can be assumed
that patients and families who had not been diagnosed may have an even greater need for
appropriate CFRD information related to screening, symptoms, and significance to aid in early
recognition and perhaps earlier diagnosis.
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Sources of Information
A concerning finding is that the majority of participants stated they only seek information
when needed. In general, patients with CF believe they have a high level of disease-specific and
treatment knowledge. Although this may be true, a problem exists if these individuals are not
fully aware of co-morbities and complications of the disease and, therefore, are not readily
seeking information. Consistent with our findings, which identified doctors and the clinic as two
of the most common sources of information, the reproductive literature has previously identified
CF providers as the preferred source of information . In addition to providers, the internet was a
popular method for obtaining health information. Patients Like Me is a site where patients can
provide personal stories and health data with the goals of obtaining information about
medications, supplements, and devices, and to connect easily with patients that have the same
condition. CFF.org is the official website of the Cystic Fibrosis Foundation. This site provides a
wide range of information for the public, patients, families, and clinicians. Information about CF,
the foundation, living with CF, and research is included. This may reflect a the current trend of
the internet’s growing popularity or may also be influenced by the restricted face-to-face contact
patients with CF have with other patients with CF. This restriction limits the ability to
participate in traditional support groups perhaps fueling the popularity of sites like Patients Like
Me.
Limitations
There are several limitation of this study. Generalizability of results is limited due to a
small sample size and convenience sample. Although CF occurs equally in males and females,
there were a higher percentage of males in this study. The most plausible explanation for the
difference would be that this was a convenience sample. Another limitation was the use of an
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investigator developed survey tool. Further testing of this survey is needed with a larger sample
size in a variety of settings. Nevertheless, despite these limitations, this study provides
important insights that can be used to guide future studies.
Results of this study suggest that knowledge gaps exist in the adult CF population related
to CFRD. Specifically, participants lack an understanding they are at risk, do not know the
symptoms of CFRD and do not understand the relationship between CFRD and lung disease.
These results, although not generalizable can guide future studies. As the CF population
continues to age and life expectancy increases, it will become critical to understand knowledge
gaps and provide appropriate and effective educational interventions. Studies are needed to
explore patients, parents’ and caregiver’s knowledge and understanding of CFRD as well as the
need to reinforce knowledge and understanding following diagnosis. Future studies will also
need to examine the increased treatment burden associated with the additional diagnosis of
CFRD as well as self-management support and guidance.
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Table 1: Sample Characteristics
Age

Sex
Male
Ethnicity
 Hispanic or Latino
 Non-Hispanic or Latino
Race
 Caucasian
 African American
 Other
Level of Education
 Grade 9-12
 Grade 12 or GED
 College 1-3 years
 College 4 years/graduate
 Graduate School/advanced degree
Employment Status
 Employed for wages
 Self employed
 Homemaker
 Student
 Unable to work
 Other (multiple status selected)
Marital Status
 Married/Life partner
 Divorced/Separated
 Widowed
 Single, never married
Treated at another CF Center
 Yes
 No
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Mean
28

SD
10.2

N

%

19

70

1
26

4
96

23
4

85
15

1
9
12
4
1

4
33
44
15
4

9
1
2
7
5
3

33
4
7
26
19
11

9
1
1
16

33
4
4
60

13
14

48
52

Chapter 3
THEORETICAL FRAMEWORK AND METHODS
Theoretical Framework

Chapter 1 provided a general introduction to the middle-range theory of Individual and
Family Self-Management (IFSMT) this chapter will delve further into the theory and highlight
how the IFSMT will would be used to guide research on self or family management of CF.
Context. Context is comprised of risk and protective factors. These factors are ConditionSpecific, Physical & Social Environment, and Individual and Family factors that challenge or
protect individuals and families as they engage in SM. Contextual factors influence the
individual’s and family’s engagement in the SM process, as well as directly influence outcomes.
Condition specific factors can include physiological, structural, or functional
characteristics of the condition that affect the amount, type, and nature of behaviors required to
manage the condition. Condition specific factors also incorporate the complexity of the condition
and/or treatment trajectory. The physical and social environment is comprised of factors such as
access to healthcare, provider or setting transitions, transportation, neighborhoods, or culture that
present barriers or improve ability for SM by the individual and family. Individual and family
factors represent circumstances that enhance or diminish SM. Examples include cognitive status,
perspectives, information processing, developmental stages, capabilities, literacy, or
resourcefulness.
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The treatment guidelines for CF recommend the use of a number of chronic maintenance
medications, as well as airway clearance and regular exercise. This self-management regimen is
time consuming and complex and requires proper use of devices. The complexity of treatment
for individuals with CF is high, and estimates suggest that the self-management regimen takes
two to three hours per day for routine care (Sawicki, Sellers, & Robinson, 2009). It has already
been established that adherence to CF treatments is poor, typically around 50% (Eakin,
Bilderback, Boyle, Mogayzel, & Riekert, 2011). A recent study by Sawicki et al 2013 observed
that although treatment complexity was highest in adults with CF, treatment complexity in all
age groups increased over a 3 year period. In addition to the increase in treatment complexity
being statistically significant, it is also clinically significant. Increases in treatment complexity,
while necessary to improve health, pose challenges to self-management and adherence to
therapies. In this case, high treatment burden and complexity would be a risk factor.
The physical and social environment is comprised of factors such as access to healthcare,
provider or setting transitions, transportation, neighborhoods, or culture that can either prevent or
enhance the ability to SM. Quitter et al (2010) states that minority status and socioeconomic
status (SES) contribute to variability in the clinical course of CF. (Quittner et al., 2010). They
confirmed the findings of Schechter et al. and found that low SES was associated with worse
pulmonary function, lower height and weight, and greater likelihood of Pseudomonas
aeruginosa (Quittner et al., 2010). Possible explanations are due to increased family stress,
exposure to environmental toxins, differences in disease self-management and culture
perceptions of chronic illness. (O'Connor et al., 2002; Quittner et al., 2010; Schechter, Shelton,
Margolis, & Fitzsimmons, 2001). Schechter et al. found that medically indigent patients with CF
suffer more serious consequences of their disease than the general population with CF.
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Medically indigent patients have a threefold risk for death, and survivors have significantly
worse pulmonary function and growth. While decreased access to health care has been identified
as an important cause of SES-related adverse outcomes in other populations, it does not appear to
play an influential role in CF; as medically indigent CF patients were found to have the same
number of outpatient specialty visits as privately insured cohorts. Possible alternative
explanations to explain the disparity in health status in spite of similar medical appointments
include nutritional inadequacies associated with poverty, a clear link exist between inadequate
nutrition and more severe lung disease. Additionally patients with a lower SES status are more
likely to be exposed to indoor and outdoor air pollution which can result in worsening lung
disease. Other hypothesized causes are increased stress and its role in immune function and
subsequently infection and decreased disease related knowledge.
Process. The key factors under Process are Knowledge and Beliefs, Self-regulation Skills,
and Social Facilitation. IFSMT proposes that persons will be more likely to engage in
recommended health behaviors if they have accurate information and accept health beliefs
consistent with behavior. Knowledge and beliefs reflect information and perceptions about a
condition or behavior and influence self-efficacy, outcome expectations, and goal congruence.
Self-efficacy refers to the degree of confidence one has of his/her ability to successfully engage
in a behavior under a variety of circumstances. Outcome expectations are a belief that
engagement in a certain behavior will result in desired outcomes. Goal congruence is a person’s
ability to resolve the confusing from competing or contradictory demands associated with health
goals. Self-regulation is an iterative process that people engage in to achieve a change in health
behaviors. This can include but is not limited to goal setting, self-monitoring, decision-making,
planning, self-evaluation, and management of responses. Social Facilitation occurs when
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relationships enhance an individual’s capacity to change. This can include social influence,
support, and collaboration.
Outcomes. The primary outcomes are related to individuals and families; however,
improvement of individual and family outcomes translates to improved outcomes for healthcare
and systems. Outcomes include proximal (short term) outcomes that lead to attainment of distal
outcomes. Proximal outcomes include individual and family self-management behaviors and
Cost of Healthcare Services. Engagement in SM behaviors may or may not affect cost of health
care services. Distal outcomes are defined as health status (as an indicator of disease trajectory),
quality of life, and cost of health (indirect and direct costs).
Conceptual Framework
Guided by the Individual and Family Self-Management Theory (Ryan & Sawin), the
purpose of this study is to examine the effects of context (Condition Specific Factors and
Physical and Social Environment) on Outcome (self-management) in CF. (Figure 2)
Methodology
This section presents the design, sample, setting, and data collection procedures are well
as the instruments and their psychometric properties, and data analysis plan.
Research Design
This study was conducted using a cross sectional descriptive design to describe conditionspecific factors (severity of child’s condition, complexity of the child’s treatment) and the social
environment (SES, depressive symptoms) for caregivers of children with CF, (2) describe
caregiver self-efficacy, knowledge, and family self-management behaviors in caregivers of
children with CF, (3) compare differences in context (depression), process (knowledge, self-
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efficacy) and outcomes (self-management behaviors) in caregivers based on SES (Medicaid vs.
private insurance), and (4) explore correlations among context, process, and outcomes.
Sample Selection and Setting
Permission was obtained from the Intuitional Review Board (IRB). A convenience
sample of caregivers of individuals with CF was recruited from the pediatric pulmonary clinic at
the Children’s Hospital of Richmond. Any caregiver, who was over the age of 18 and identified
as a caregiver to a child/adolescent under the age of 18 with a diagnosis CF for at least 9 months
was invited to participate. Caregivers were excluded if they were unable to read and write in
English.
Instruments and Measures
The instruments that were used in this study included a demographic questionnaire,
medical record review. In addition to the demographic questionnaire and medical record review
other context variables were measured using a treatment complexity score, a visual analog scale
(VAS), and the Patient Health Questionnaire (PHQ-9). Additional process variables were
measured and included the Perceived Health Competence Scale (PHCS), the Mountain West CF
Consortium, and the CF Knowledge and Attitudes test. The outcome variable was measured by
the Self Management Questionnaire.
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Figure 2: Individual & Family Self-Management Theory Applied to Family Self-Management of Children with Cystic Fibrosis
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Individual Characteristics
Demographic questionnaire (Caregiver): A 14-item self report questionnaire provided
information on the caregiver and included age, gender, race, marital status, highest education
completed, employment status, relationship to the child with CF, and information regarding the
number of other children in the family (see Appendix A).
Demographic characteristics (Child): The following characteristics of the child were
collected as part of the caregiver questionnaire; gender, age and insurance status. The clinical
characteristics of the child included; lung function, height/weight/BMI percentile, and
medications/treatments were obtained from the medical record.
Context Variables
Treatment complexity. Treatment complexity can include the number of drugs, route of
administration, dosing frequency, and additional directions for taking the drug for example,
relationship to timing with foods, set up of device to deliver drug (George, Phun, Bailey, Kong,
& Stewart, 2004). The Treatment Complexity Scale (TCS) was developed by Sawicki et al.
(2010) in an effort to evaluate CF treatment complexity (see Appendix B). The TCS is a total
score of 0-63, determined by assigning a complexity of 1, 2, or 3 for each therapy. The
complexity score is based on daily frequency, duration, and ease of administration. The tool
includes 37 chronic therapies that were captured as part of the longitudinal Epidemiology Study
of Cystic Fibrosis (ESCF). Oral medications and metered-dose inhalers are assigned a score of 1
(20 items); once-daily nebulized therapies and pancreatic enzyme are assigned a score of 2 (8
items), and airway clearance, twice-daily nebulized therapies, use of oxygen, continuous positive
airway pressure (CPAP), bi-level positive airway pressure (BiPAP), and insulin or enteral
supplements are assigned a score of 3 (9 items). A total score is calculated by summing the
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scores of all therapies and can range from 0-63. Higher scores indicate higher treatment
complexity. Since the development of the tool, several new treatments for CF have been
approved. The first is an oral medication that is taken twice a day. Similar to other twice a day
medications this will be scored as 2. The second is a nebulized therapy, however, unlike other
nebulized therapies which are administered once or twice daily, aztreonam is used 3 times a day.
Although the treatment time is shorter (3-5 min compared to 10-20) it does require preparation
and cleaning of nebulizer and will therefore receive a score of 3. With the additions of these two
treatments the maximum score will be 68.
Disease severity. Disease severity was measured using information from pulmonary
function testing. The pulmonary function testing was performed by the respiratory therapist as
part of the routine clinic visit using the MCG diagnostics pulmonary function equipment with
Breeze Suite © software (St. Paul MN). The forced expiratory volume in one second (FEV1) was
used and is classified into three groups: mild disease (FEV1>70%), moderate disease (FEV1 41–
69%) and severe disease (FEV1<40%). This disease severity classification has been applied and
adopted internationally in both the medical and psychosocial literature and is used as the
standard for the epidemiological study in CF, and is the classification used in the Cystic Fibrosis
Foundation (CFF) patient registry (Cystic Fibrosis Patient Registry, 2016 Annual Data Report).
As an additional measure of disease severity, a visual analog scale (VAS) was used to gauge how
the parent/caregiver viewed the child’s health (see Appendix C). Participants were asked to rate
their perception of the child’s health by placing an X on a 10cm line. One side of the line (0 cm)
represented death and the other end (10 cm) was perfect health. A score reflecting the position
of the X on the line represented the perception of their child’s severity.
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Depression. The Patient Health Questionnaire (PHQ-9) was used to screen for depression
(see Appendix D). In 2015, the International Committee on Mental Health in Cystic Fibrosis
began recommending the use of this tool. The PHQ-9 is brief, reliable, and valid with appropriate
cut off scores for detecting depressive symptoms. The score ranges from 0-27 with a
recommended interpretation as follows: 1-4 minimal depression, 5-9 mild depression, 10-14
moderate depression, 15-19 moderately severe depression, and 20-27 severe depression. A cut
off score of ≥ 10 has a sensitivity and specificity of 88% for major depression. Internal
consistence is high with Chronbach’s alpha 0.86-.89 (Kroenke et al., 2001).
Process Variables
Self-efficacy. To provide a broader assessment of self-efficacy, both general and diseasespecific self-efficacy were considered. General self-efficacy was measured by the Perceived
Health Competence Scale (PHCS) (see Appendix E). The PHCS contains 8 items to which
responses are chosen from a 5 point Likert scale ranging from 1 = strongly disagree to 5 =
strongly agree. There are 4 positively formulated items and 4 negatively formulated items. The
four negatively worded items were re-coded so that a higher total score reflected self-efficacy
(competence to manage their child’s health). The items add up to a total score with a range from
8-40; higher scores indicating higher levels of competence. The PHCS has been administered to
wide variety of participants with a degree of health conditions. The psychometric properties
suggest a high degree of internal consistency and satisfactory test-retest stability. Across five
samples (young adult students, working adults, and persons with a chronic illness; rheumatoid
arthritis) in the original study of the PHCS there was high internal consistency with Cronbach’s
alpha ranging from 0.82-0.90 (Smith, Wallson, Smith, 1995).
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The Mountain West Cystic Fibrosis Consortium Questionnaire (MWCFC-Q) developed
by McDonald, Christensen, Lingard, & Walker, 2009) was used to measure caregivers diseasespecific self-efficacy (see Appendix F). This Likert-type questionnaire (0=not at all confident to
10=completely confident) is divided into four sections 1) demographics, 2) food security, and 3)
CF nutrition knowledge, and 4) confidence in CF management. In this study, only the 18 item
section on confidence in CF management will be used. This section, which includes the three
domains of CF care, allows the participants to rate their self-efficacy or confidence in each of
these 3 domains: Task, Nutrition, CF Care center recommendations. Task measured the ability to
manage CF care (pulmonary therapies and medications, nutrition addresses their ability to
manage nutrition therapy and food related behaviors, and CF care center recommendations
aimed to measure the participants perceived ability to follow the CF care center
recommendations. The Cronbach alpha for the self-efficacy subscale has been 0.92 (McDonald
et al, 2009.
Cystic fibrosis knowledge. CF knowledge was measured by the CF Knowledge and
Attitudes Questionnaire developed by Siklosi, Gallagher and McKone (2010) (see Appendix G).
The original questionnaire contains 49 fixed response questions, 2 open ended questions, and 9
questions combining both. The questionnaire is divided into three sections: demographics, CF
knowledge test, and attitude and education questions. For the purpose of this study the CF
knowledge test was used. The CF knowledge questionnaire is further divided into three sections:
general knowledge (7 items), lung/GI issues (10 items), and reproductive/genetics knowledge (9
items). The CF knowledge test is scored by earning 1 point for each correct answer and 0 points
for an incorrect answer or the choice “I’m not sure”. A maximum score of 32 is possible. The
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Cronbach’s alpha for the overall test has been reported as 0.75. The interclass correlation
coefficients ranged from 0.76-0.97 and indicate good test-retest reliability (Siklosi et al 2010).
Proximal Outcomes
Family Self-Management of CF. Self-management of CF was measured using The SelfManagement Questionnaire for Cystic Fibrosis (SMQ-CF) (Sockrider et al., 1996). This
instrument has both a caretaker and adolescent version, for this study the caretaker version was
used (see Appendix H). The SMQ-CF measures behaviors that include skills characteristically
used for management of both pulmonary and gastrointestinal symptoms in CF. The SMQ-CF is
a 46 item written questionnaire using a 5 five point rating scale. Responses rank from 1 = never
used to 5 = always used. Items address behaviors reflecting monitoring and treatment of
respiratory infection, respiratory therapies, malabsorption and malnutrition. A ‘skip pattern’ is
included for patients who do not have pancreatic insufficiency and also for those who have not
had an experience with lower respiratory infections (bronchitis, bronchiolitis, or pneumonia).
Due to the “skip pattern”, each of the sections (respiratory surveillance, respiratory treatment,
CPT/RT, malabsorption, and nutritional surveillance) were examined separately based upon
whether or not the treatment was required for the child. For example, all caregivers responded to
the respiratory surveillance domain; however, if their child did not have an infection, the section
on treatment could be “skipped”. Limitations in determining validity exist as there is no “gold
standard” for comparison. Internal consistency was high with a Cronbach’s alpha coefficient of
0.95 for the total scale (Sockrider et al, 1996).
Data Collection
Participant recruitment was initiated following the IRB approval and a meeting with the
clinic to review the project took place. Prior to the weekly CF clinic a pre-clinic meeting was
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held and the list of patients was reviewed for participation. Participants were approached during
the outpatient clinic visit by the researcher. They were informed about the study verbally and by
review of the written consent, if they decided to participation informed consent (Appendix I) was
obtained. Following the consent process participants were given a copy of the questionnaires.
Participants had the opportunity to complete the questionnaires while at their visit or return them
by mail via a pre-paid addressed envelope. Participants were counseled not to include any
identifying information (i.e.: copy of consent) when returning by mail.
Research Subjects Protection
The only anticipated risk of participation in the study was the time it would take to
complete the surveys. Participants were able to take breaks as needed. Participants names did not
appear on the questionnaires and their answers were kept confidential. The questionnaires were
kept in a locked file cabinet in the researcher’s office.
Statistical Analysis
All data were analyzed using SPSS (v. 24, Chicago, IL). Each instrument was evaluated
for reliability using Cronbach’s alpha coefficients. Descriptive statistics were computed for
sample demographics and all other variables using frequency distribution and percent for
categorical variables and mean and SD based on distribution for continuous variables. Variables
were inspected for normal distribution and means and SD were reported for those variables that
were normally distributed. Medians values were provided for non-normally distributed values.
Because the normal distribution assumption was not met, Mann-Whitney U test were conducted
to compare insurance coverage groups (private, Medicaid) regarding depression, self- efficacy,
knowledge, and self-management behaviors. Pearson’s correlation coefficient (r) was used to
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determine relationships between context and process variables and self-management behaviors
including treatment complexity, disease severity, knowledge, self-efficacy and depression.
Summary
The purpose of this study was to describe and explore the relationship between context,
process and outcomes variables in caregivers of children with CF using a cross sectional design.
The data was analyzed using SPSS (v.24). In Chapter 4 an additional description of the study as
well as the results are presented in manuscript form.
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Chapter 4
INFLUENCE OF CONTEXT AND PROCESS FACTORS ON FAMILY SELF
MANAGEMENT IN CAREGIVERS OF CHILDREN WITH CYSTIC FIBROSIS
Abstract
Purpose: The purposes of this pilot study were to: (1) describe condition-specific factors and the
individual and family factors for caregivers of children with Cystic Fibrosis (CF), (2) describe
caregiver self-efficacy, knowledge, and family self-management behaviors in caregivers of
children with CF, (3) compare differences in context (depression), process (knowledge, selfefficacy) and outcomes (family self-management behaviors) in caregivers based on SES
(Medicaid vs. private insurance), and (4) explore correlations among context, process, and
outcomes.
Design and Methods: Participants for this cross-sectional descriptive study were caregivers of
individuals with CF who were under the age of 18 and diagnosed with CF for at least 9 months.
The variables were selected using the Individual and Family Self-management Theory (IFMST)
as a framework. Descriptive statistics were computed for sample demographics and all other
variables. Mann-Whitney U test were conducted to compare insurance coverage groups (private,
Medicaid) regarding knowledge, self- efficacy and depressive symptoms. Pearson’s correlation
coefficient (r) was used to determine relationships between context and process variables and
self-management behaviors including treatment complexity, disease severity, knowledge, selfefficacy, and depressive symptoms.
Results: Overall this study of primarily female caregivers was described as having high selfefficacy, and average knowledge. Deficits were noted in the areas of reproductive and genetic
knowledge. This study found differences between Medicaid and private insurance groups related
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to knowledge. There were significant relationships between perceived disease severity and CF
specific self-efficacy and nutritional surveillance as well as general self-efficacy and respiratory
surveillance. The children with CF in this study had moderate treatment complexity and normal
to mild lung function impairment.
Practice Implications This was the first time that the IFMST was used to guide CF
research. The IFMST would provide a consistent framework to guide future studies aimed at
identifying factors that influence self-management behaviors of CF in patients and their
caregivers. Based on the knowledge gaps identified, clinicians need to continually reinforce
caregivers understanding of the disease and in particular with regards to reproductive and
genetics knowledge. Additional studies are needed.

Keywords: Cystic Fibrosis, Treatment Complexity, Self-efficacy, Self-management, Individual
and Family Self-Management Theory
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Introduction
Cystic fibrosis (CF), with a prevalence of 1 in 3500 live births, is characterized by a
defective gene that results in the production of thick, tenacious mucus that obstructs the lungs
and the pancreas. CF is a multisystem disease that primarily affects the respiratory and
gastrointestinal systems. Co-morbidities are common among patients with CF and include
gastrointestinal symptoms, nutritional failure, diabetes, bone disorders, sinus problems, and
mental disorders.
In the 1950’s, a diagnosis of CF resulted in a life expectancy of only 15 years; however,
with continued advances in medical and nutritional management, life expectancy has improved
significantly and is now 37.4 years. Of the approximately 30,000 children and adults in the
United States with CF, more than 45% are over the age of 18 years ("About CF," 2017). The
improved life expectancy has been achieved by employing complex management including
multiple interventions to both prevent and treat manifestations of CF and its co-morbities.
Increasing survival rates in CF are, in large part, due to more aggressive management of
the disease. The regimen may include nebulized or oral antibiotics, enzymes or nutritional
supplements, insulin, chest physical therapy and exercise. The majority of individuals with CF
require care at home. Regardless of the age of the individual with CF, management is rarely a
solo task; family members including parents, grandparents, siblings, and spouses often play an
active role in assisting with care.
The middle-range theory of Individual and Family Self-Management (IFSMT) (Figure 1)
provides a theoretical framework to guide research on self or family management of CF because
it suggests that self-management (SM) is a complex dynamic phenomenon consisting of 3
dimensions: context, process, and outcomes (Ryan & Sawin, 2009). Individual and family self40

management includes incorporation of health-related behaviors into an individual or family’s
daily functioning. This theory combines and expands on previous work related to individual selfmanagement and adds a focus on dyads within the family or family unit. Although there are
established relationships among variables in the model, a descriptive theory reveals the substance
of a situation, however does not specify the strength and direction of relationships among
components. When individual self-management is viewed as a systems theory, a change in one
component of the system leads to changes in the entire system. Combining the individual and
family perspectives improves our understanding of shifts in balance and roles as family members
often evolve and change. For individuals and families, the management of chronic health
conditions leads to improving health outcomes, enhanced quality of life and realignment of
healthcare expenditures (Ryan & Sawin, 2009).
The purposes of this pilot study were to: (1) describe condition-specific factors (severity
of child’s condition, complexity of the child’s treatment) and the social environment (SES,
depressive symptoms) for caregivers of children with CF, (2) describe caregiver self-efficacy,
knowledge, and family self-management behaviors in caregivers of children with CF, (3)
compare differences in context (depressive symptoms), process (knowledge, self-efficacy) and
outcomes (self-management behaviors) in caregivers based on SES (Medicaid vs. private
insurance), and (4) explore correlations among context, process, and outcomes.
Methods
Design, sample, setting and data collection procedures
Participants for this cross-sectional descriptive study were caregivers of individuals with CF who
were under the age of 18 and diagnosed with CF for at least 9 months. Caregivers were excluded
if they were unable to read and write in English. This study was conducted at an academic
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medical center with a pediatric CF center in the southeast region of the United States.
Participants were approached during an outpatient clinic visit, consented and given a copy of the
questionnaires. Participants had the opportunity to complete the questionnaires while at their
visit or return them by mail.
Variables and measures
In the following section variables and measures will be organized by the conceptual framework.
Demographic and Clinical Characteristics of the Sample
Demographic information collected on the caregiver included age, gender, race, marital status,
highest education completed, employment status, relationship to the child with CF, and
information regarding the number of other children in the family. Demographic characteristics
collected on the child with CF included gender, age and insurance status (used as a measure of
SES). Clinical characteristics of the child included; lung function, height/weight/BMI percentile,
and medications/treatments were obtained from the medical record.
Context Variables
Treatment complexity. Treatment complexity can include the number of drugs, route of
administration, dosing frequency, and additional directions for taking the drug for example,
relationship to timing with foods, set up of device to deliver drug (George, Phun, Bailey, Kong,
& Stewart, 2004). The Treatment Complexity Scale (TCS) was developed by Sawicki et al.
(2010) in an effort to evaluate CF treatment complexity. The TCS is a total score of 0-63,
determined by assigning a complexity of 1, 2, or 3 for each therapy. The complexity score is
based on daily frequency, duration, and ease of administration. The tool includes 37 chronic
therapies that were captured as part of the longitudinal Epidemiology Study of Cystic Fibrosis
(ESCF). Oral medications and metered-dose inhalers are assigned a score of 1 (20 items); once42

daily nebulized therapies and pancreatic enzyme are assigned a score of 2 (8 items), and airway
clearance, twice-daily nebulized therapies, use of oxygen, continuous positive airway pressure
(CPAP), bi-level positive airway pressure (BiPAP), and insulin or enteral supplements are
assigned a score of 3 (9 items). A total score is calculated by summing the scores of all
therapies. Higher scores indicate higher treatment complexity. Since the development of the
tool, several new treatments for CF have been approved. The first is an oral medication that is
taken twice a day. Similar to other twice a day medications this will be scored as 2. The second
is a nebulized therapy, however, unlike other nebulized therapies which are administered once or
twice daily, aztreonam is used 3 times a day. Although the treatment time is shorter (3-5 min
compared to 10-20) it does require preparation and cleaning of nebulizer and will therefore
receive a score of 3.
Disease severity. Disease severity was measured using information from pulmonary
function testing. The pulmonary function testing was performed by the respiratory therapist as
part of the routine clinic visit using the MCG diagnostics pulmonary function equipment with
BreezeSuite© software (St. Paul MN). The forced expiratory volume in one second (FEV1) was
used and is classified into three groups: mild disease (FEV1>70%), moderate disease (FEV1 41–
69%) and severe disease (FEV1<40%). This disease severity classification has been applied and
adopted internationally in both the medical and psychosocial literature and is used as the
standard for the epidemiological study in CF, and is the classification used in the Cystic Fibrosis
Foundation (CFF) patient registry (Cystic Fibrosis Patient Registry, 2016 Annual Data Report).
As an additional measure of disease severity, a visual analog scale (VAS) was used to gauge how
the parent/caregiver viewed the child’s health. Participants were asked to rate their perception of
the child’s health by placing an X on a 10cm line. One side of the line (0 cm) represented death
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and the other end (10 cm) was perfect health. A score reflecting the position of the X on the line
represented the perception of their child’s severity.
Depression. The Patient Health Questionnaire (PHQ-9) was used to screen for
depression. In 2015, the International Committee on Mental Health in Cystic Fibrosis began
recommending the use of this tool. The PHQ-9 is brief, reliable, and valid with appropriate cut
off scores for detecting depressive symptoms. The score ranges from 0-27 with a recommended
interpretation as follows: 1-4 minimal depression, 5-9 mild depression, 10-14 moderate
depression, 15-19 moderately severe depression, and 20-27 severe depression. A cut off score of
≥ 10 has a sensitivity and specificity of 88% for major depression. Internal consistence is high
with Chronbach’s alpha 0.86-.89 (Kroenke et al., 2001). In the present study, Cronbach’s alpha
was 0.82.
Process Variables
Self-efficacy. To provide a broader assessment of self-efficacy, both general and diseasespecific self-efficacy were considered. General self-efficacy was measured by the Perceived
Health Competence Scale (PHCS). The PHCS contains 8 items to which responses are chosen
from a 5 point Likert scale ranging from 1 = strongly disagree to 5 = strongly agree. There are 4
positively formulated items and 4 negatively formulated items. The four negatively worded items
were re-coded so that a higher total score reflected self-efficacy (competence to manage their
child’s health). The items add up to a total score with a range from 8-40; higher scores indicating
higher levels of competence. The PHCS has been administered to wide variety of participants
with a degree of health conditions. The psychometric properties suggest a high degree of internal
consistency and satisfactory test-retest stability. Across five samples (young adult students,
working adults, and persons with a chronic illness; rheumatoid arthritis) in the original study of
44

the PHCS there was high internal consistency with Cronbach’s alpha ranging from 0.82-0.90
(Smith, Wallson, Smith, 1995). The Cronbach’s alpha in this study was 0.70.
The Mountain West Cystic Fibrosis Consortium Questionnaire (MWCFC-Q) developed
by McDonald, Christensen, Lingard, & Walker, (2009) was used to measure caregivers diseasespecific self-efficacy. This Likert-type questionnaire (0=not at all confident to 10=completely
confident) is divided into four sections 1) demographics, 2) food security, and 3) CF nutrition
knowledge, and 4) confidence in CF management. In this study, only the 18 item section on
confidence in CF management will be used. This section, which includes the three domains of
CF care, allows the participants to rate their self-efficacy or confidence in each of these 3
domains: Task, Nutrition, CF Care center recommendations. Task measured the ability to
manage CF care (pulmonary therapies and medications, nutrition addresses their ability to
manage nutrition therapy and food related behaviors, and CF care center recommendations
aimed to measure the participants perceived ability to follow the CF care center
recommendations. The Cronbach alpha for the self-efficacy subscale has been 0.92 (McDonald
et al, 2009), and in the present study it was 0.88.
Cystic fibrosis knowledge. CF knowledge was measured by the CF Knowledge and
Attitudes Questionnaire developed by Siklosi, Gallagher and McKone (2010). The original
questionnaire contains 49 fixed response questions, 2 open ended questions, and 9 questions
combining both. The questionnaire is divided into three sections: demographics, CF knowledge
test, and attitude and education questions. For the purpose of this study the CF knowledge test
was used. The CF knowledge questionnaire is further divided into three sections: general
knowledge (7 items), lung/GI issues (10 items), and reproductive/genetics knowledge (9 items).
The CF knowledge test is scored by earning 1 point for each correct answer and 0 points for an
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incorrect answer or the choice “I’m not sure”. A maximum score of 32 is possible. The
Cronbach’s alpha for the overall test has been reported as 0.75. The interclass correlation
coefficients ranged from 0.76-0.97 and indicate good test-retest reliability (Siklosi et al 2010).
The Cronbach’s alpha for the overall test was 0.80 in this sample.
Proximal Outcomes
Family Self- Management of CF. Self-management of CF was measured using The SelfManagement Questionnaire for Cystic Fibrosis (SMQ-CF) (Sockrider et al., 1996). This
instrument has both a caretaker and adolescent version, for this study the caretaker version was
used. The SMQ-CF measures behaviors that include skills characteristically used for
management of both pulmonary and gastrointestinal symptoms in CF. The SMQ-CF is a 46 item
written questionnaire using a 5 five point rating scale. Responses rank from 1 = never used to 5 =
always used. Items address behaviors reflecting monitoring and treatment of respiratory
infection, respiratory therapies, malabsorption and malnutrition. A ‘skip pattern’ is included for
patients who do not have pancreatic insufficiency and also for those who have not had an
experience with lower respiratory infections (bronchitis, bronchiolitis, or pneumonia). Due to
the “skip pattern”, each of the sections (respiratory surveillance, respiratory treatment, CPT/RT,
malabsorption, and nutritional surveillance) were examined separately based upon whether or not
the treatment was required for the child. For example, all caregivers responded to the respiratory
surveillance domain; however, if their child did not have an infection, the section on treatment
could be “skipped”. Limitations in determining validity exist as there is no “gold standard” for
comparison. Internal consistency was high with a Cronbach’s alpha coefficient of 0.95 for the
total scale (Sockrider et al, 1996). In the present study the overall Cronbach’s alpha was 0.87 and
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the subscales were as follows: respiratory surveillance 0.94, respiratory treatment, 0.88, CPT/RT,
0.93, malabsorption, 0.81, and nutritional surveillance, 0.88.
Statistical analysis
All data were analyzed using SPSS (v. 24, Chicago, IL). Descriptive statistics were
computed for sample demographics and all other variables using frequency distribution and
percent for categorical variables and mean and SD based on distribution for continuous variables.
Variables were inspected for normal distribution and means and SD were reported for those
variables that were normally distributed. Medians values were provided for non-normally
distributed values. Because the normal distribution assumption was not met, Mann-Whitney U
test were conducted to compare insurance coverage groups (private, Medicaid) regarding
depression, self- efficacy, knowledge, and family self-management behaviors. Pearson’s
correlation coefficient (r) was used to determine relationships between context and process
variables and self-management behaviors including treatment complexity, disease severity,
knowledge, self-efficacy and depression.
Results
Sample
Thirty three individuals were invited to participate, 31 consented and 19 consented and returned
questionnaires. There was not adequate data or either the parents or the child to make any
comparisons between completers and non-completers. Sample characteristics for parents and
caregivers are presented in Table 1. The average age of the caregiver participants was 40.71
years (SD=11.06 year; range = 25-69 years); 94% were women, 88.9% were Caucasian, and
80% were married. Most (87.5%) had at least one other biological child. The majority (81%) of
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these participants had completed college or graduate school. Seventy-tree percent of children had
private insurance.
Characteristics of the child are included in Table 2. The majority of the children and
adolescents were male (60%) with a mean age of 9.86 (SD=4.42 range= 1-16). The mean BMI
percentile (%) was 49.83 (SD= 26.67 range= 3.46-96.75) suggesting that the BMI % for this
cohort of children and adolescents is adequate. Additionally there was one participant under the
age of 2; therefore, weight to length was utilized to characterize their nutritional status. The CF
foundation recommends BMI % of 50% or greater. Five of these children with CF were also
reported to have other health problems including 4 with asthma.
Descriptive statistics
Treatment complexity. Overall treatment complexity was 12.95 (SD=3.78, range 5-21).
The mean treatment complexity in children ages 0-6 was 8, 7-13 years was 13.75 and 14-17
years was 14.25 suggesting that treatment complexity in this sample is substantial and increases
with age. Standard therapies include nutritional support including vitamin and enzyme
supplementation. Approximately 80% reported that their child received vitamin supplementation
and 84% were on pancreatic enzyme replacement. Although the max score of this tool is
significantly higher than the mean treatment complexity of this group it is important to put it into
context to understand that a “lower” value could still be considered complex. For example a
score of 10 could be representative of 12-15 pills, a twice a day inhaler, pancreatic enzymes 3-6
times a day, a nebulized medication treatment lasting 15 minutes/treatment (twice daily) and
airway clearance lasting 20 minutes (twice daily).
Disease severity. The average FEV1 percent predicted was 98.37 (SD= 15.83, range 66120). Based on FEV1 classification, the majority of these children (87.5%) had mild lung disease.
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Caregivers’ perception of severity of their child’s disease severity (on the VAS) was 8.04
(SD=1.45, range= 4.5-9.9) indicating that their perception of the severity of disease was close to
“perfect health”.
Depression. Overall, low rates of depressive symptoms were reported by the caregivers.
The mean was 2.76 (SD=3.79 range 0-12), with a maximum score of 27 possible. Two
participant’s scores represented mild depression and one participant score indicated moderate
depression.
Self-efficacy. Both general and disease specific measures of the caregivers’ self-efficacy
are reported in Table 3. The mean of general self-efficacy was 34.28 (SD=2.85; range 31-39)
with a maximum possible score of 40. The CF-specific self-efficacy mean score was 163.89
(SD=16.81; range 122-180). The maximum score achievable is 180. Overall this represents
moderate to high levels of confidence in ability to manage the child’s illness and treatment.
Knowledge. Knowledge scores, which were converted to a scale of 1-100 revealed an
overall caregiver score of 70.64 (SD=15.32, range= 39.3-96.40) and subgroup scoring for
general knowledge, lung/GI/ and reproductive/genetic were 65.7 (SD=21.1, range- 14.2-85.7),
81.48 (SD=12.65, range=58.3-100), 60.5 (SD=23.26, range= 11.1-100) respectively.
Participants’ knowledge was greatest in the area of lung and GI information and the lowest in
reproductive and genetic information.
Self-management. Self-management was divided into five subsections. Respiratory
surveillance and treatment mean scores were 77.62 (SD=30.25; range= 0-100) and 87.19
(SD=11.47; range= 65.5-100) respectively. Self-management of chest and respiratory physical
therapy had a mean of 72.65 (SD=31.27; range= 7.4-100). The subsections related to
malabsorption and nutritional surveillance had a mean of 82.6 (SD=20.92; range 50-100) and
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82.55 (SD=17.78; range =34.4-100). Participants’ self-management behaviors were greatest in
respiratory treatment followed by malabsorption and nutritional surveillance. The lowest selfmanagement behaviors were in the chest and respiratory therapy subsections.
Group Comparisons
Comparisons were made between participants with Medicaid vs. private insurance.
Results are shown in Table 4. Overall participants with Medicaid had lower scores for total
knowledge (including all sub categories), lower self-efficacy on both disease specific and generic
scales, and higher depression ratings. A Mann Whitney U test was used to determine if the
difference in the two medians were significantly different between groups. The results were
significant for general knowledge (U=9.5, p= .038), reproductive and genetic knowledge (U=8,
p= .019) and total knowledge (U=8, p= .026). There were no significant differences between
groups with regards to depressive symptoms, lung specific knowledge, self-efficacy, or selfmanagement behaviors.
Correlation analysis
Table 5 includes bivariate correlations between context and process variables and selfmanagement behaviors represented by the model, including treatment complexity, disease
severity, depressive symptoms, self-efficacy, and knowledge. There was one significant
correlation identified between context factors (treatment complexity, perception of the child’s
health status) and self-management. Caregivers’ perception of their child’s disease severity was
negatively related to diet self-management behaviors (r= -.060, p= .008). This suggests that as
the parent’s perception their child’s health improved, self-management behaviors related to
nutritional surveillance were less of a priority. Although pancreatic sufficiency vs. insufficient
information was not collected this may help explain this finding. Pancreatic sufficient patients
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overall have improved health (perhaps reflected in caregivers’ perception), they also do not
typically require the same level of diet management as pancreatic insufficient patients. There
were significant correlations noted between process factors (self-efficacy, and knowledge) and
self-management. General SE was negatively correlated with respiratory surveillance (r= -.490
p= 0.039). Conversely, disease specific SE was positively correlated with malabsorption (r=.637,
p=.011) and nutritional surveillance components of self-management (r=.662 p= .003). Better
knowledge of lung issues correlated with higher CPT/RT self-management (r=0.602 p=0.014)
suggesting that in this case greater knowledge may positively affect behavior as it relates to
CPT/RT. There were no significant correlations between treatment complexity or depressive
symptoms and self-management.
Discussion
The majority of the caregiver participants were female and Caucasian. In one study of
caregivers of children with CF, the mean age of caregivers was similar to the mean age of our
sample (Driscoll, Montag-Leifling, Acton, Modi, 2009). The breakdown of male versus female
caregivers our sample was significantly different; however, the authors (Driscoll et al) reported
specifically seeking out male caregivers as they have been previously overlooked in research.
The characteristics of the children in our study are similar to what is seen in the US population of
CF patients. The CFF Registry data reports that the majority of individuals with CF are
Caucasian (93.8%) and which was similar to our study population. We also had a similar gender
breakdown with slightly more males than females. There were differences however seen
between those with private insurance versus Medicaid. Our sample reported 73.7% private
insurance whereas the Registry Data reported 59.5%, and Medicaid 44.8% versus our 26.3%
(Registry Data 2015).
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Treatment Complexity
The CFF maintains detailed clinical guidelines to aid the practitioner and individual
/family with CF and includes various recommended treatments. Based on current CF chronic
care guidelines, individuals with CF would be expected to be on multiple respiratory and nonrespiratory treatments daily In general the sample appeared to be “following” the guidelines.
Approximately 80% reported that their child received vitamin supplementation and 84% were on
pancreatic enzyme replacement. Additionally 100% of participants were prescribed chest
physical therapy and/or respiratory therapy (CPT/RT). However, it is important to note that in
order to fully assess if individuals are prescribed “appropriate” medications, a number of
additional factors including: genotype, bacterial presence in the lungs, and CFRD status would
have needed to be collected.
To date there are limited published findings that used this measure of treatment
complexity, the TCS. In the development of the TCS, Sawicki et al (2013) only included
participants ages 6 and up. Ages were classified 6-13- child, 14-17 adolescent, and 18+ adults. In
2005 the mean TCS for child and adolescents were 12.4, and 12.6 respectively. The current study
showed a mean of 8 in the under 6 year old group and in children between 6 and 13, a mean of
13.75, and in adolescents a mean of 14.25. These results were similar to the results published in
2013 reporting a mean TCS of 12.4 and 12.6 respectively. One possible explanation for the
increase in scores could be the approval of two new Cystic Fibrosis transmembrane conductance
regulators (CFTR), modifiers aimed at treating the underlying defect in CF. Ivacaftor/Kalydeco
(potentiator of CFTR) and combination ivacaftor and lumacaftor/Orkambi (corrector of CFTR)
are now considered standard of care for individuals with certain gene mutations. Forty-eight
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percent of the children with CF in our sample were prescribed either ivacaftor or the combination
of ivacaftor/lumacaftor resulting in an increase in treatment complexity of 2 points.
Disease Severity
The average FEV1 in this group was high, with 6 of the 16 children having values
exceeding 100% predicted. It is important to note that although FEV1 is widely used in CF
research it is not a sensitive measure of early lung disease. Our findings showed the majority of
children with CF have mild impairment in pulmonary function.
Caregiver perception of child’s disease severity based on a VAS continuum from “death”
to “perfect health” showed that overall perception trended towards “perfect health”. This
positive perception suggests that caregivers are optimistic about their child’s health. One could
speculate that the increasing life expectancy and the fairly recent approval of CFTR modulators
may play a role. Additionally these children in this study are relativity “healthy” as
demonstrated by high lung function, limited co-morbidities, and stable weights. To date there
have been no other studies using the VAS in this manner however there are studies in other
chronic diseases that health is positively perceived even in the face of chronic illness.
Depression
The findings of this study show that 16% of caregivers have symptoms of depression as
evidence of scores greater than 5. We also found that the group with Medicaid had higher rates
of depressive symptoms. Increased rates of depression in individual with chronic disease and
their caregivers have been reported in the literature (Pinquart, & Shen, 2011). Results from a
single center study report looking at depression in caregivers of CF found 20-35% increased rate
of depression over the normal population (Latchford & Duff 2013). Driscoll et al. (2009) also
found that 20-28% of female had increased depressive symptoms. In 2015, the CFF created new
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care guidelines for the screening and treating depression and anxiety in people with CF and their
caregivers. They recognized the need for a streamlined approached and recommended the use of
the PHQ9 for screening (Quittner et al. 2015). By providing CF centers an easy to administer
tool with specific guidelines on how to handle the results this streamline approach will hopefully
lead to earlier identification of depressive symptoms, therefore earlier referrals and treatment. It
will also be helpful as individuals with CF transfer to other pediatric CF centers or transition to
adult centers as there will be a record of baseline depressive symptoms for comparison.
Self-efficacy
The findings of this study showed that both general and disease specific self-efficacy
were relatively high in this population. Although the overall disease specific self-efficacy was
high there were several areas identified that participants were less confident. These related to
how confident they were in manage feeding/eating/mealtime behavior issues in their child with
CF. The other area that was identified was and the ability to manage their child’s CF in such a
way that emotional distress does not affect everyday life. While self-efficacy has been explored
in detail in several chronic conditions, it has not yet been fully explored in CF. However,
chronic disease literature has demonstrated that it is crucial for caregivers of children with CF
are confident in their ability to manage the complexities of the treatment. Therefore, studies to
examine the role of caregiver self-efficacy should be considered.
Knowledge
Findings of this study were consistent with previous research that identified possible
knowledge gaps-- specifically related to reproduction and genetics. Our findings indicated,
overall, that participants’ knowledge of lung and GI topics (physiotherapy, lung infections, and
malabsorption) was greatest, and the lowest in reproductive health and genetics topics (fertility
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and recurrence risk). Siklosi el al. (2010) found that although adult CF patients understood most
aspects of their disease, knowledge deficits related to genetics and reproduction were identified.
These same researchers also reported significant associations between knowledge scores and
gender and education attainment but did not find significant differences with SES. Being female
and having higher education attainment were both independent predictors of higher CF
knowledge scores. In the current study, group comparisons were made between individuals with
private or Medicaid. Our findings showed that participants with Medicaid had lower knowledge
scores. Gage (2012) also found that both males and females lack disease specific reproductive
health knowledge and further identified the need for specific sexual and reproductive education.
As the CF population continues to live longer and healthier lives it will be critical for
improvements in knowledge regarding genetics and reproduction.
Self -management
The management of CF is more complex than just implementing prescribed therapies; it
requires patients and families to monitor symptoms and make decisions to modify therapies
appropriately. Therefore, skills related to monitoring, decision-making, communicating, and
coping are necessary to enable patients and families to perform self-management behaviors
(Parcel et al., 1994). Previous research has demonstrated that individuals with CF are able to
perform 30-70% of these self-management tasks (Abbot, Dodd, & Webb, 1996). Patients with
CF, however, have more difficulty performing some treatments than others with the highest
percent of self-management behaviors in antibiotics management and the lowest in
physiotherapy behaviors (Abbot et al., 1996). The results of this study found that selfmanagement was greatest with regards to respiratory and nutritional surveillance. This is not
surprising for several reasons. First both respiratory and nutrition are the major focus areas of

55

care in this population. Secondly both are able to be measured (lung function, BMI) and are used
as “benchmarks” for how well an individual with CF is doing. Finally, the leading cause of death
in this population is directly related to respiratory health and nutrition.
Limitations
There are several limitations in the study, most notably the small sample size. There were
12 caregivers who consented but never returned the questionnaires which may have led to
potential selection bias. Interestingly of the questionnaires that were not returned the majority did
not have FEV1 percent predicted results which indicate a younger age of the child with CF, this
could possibly suggest limited time for parents of younger children to complete surveys. Often it
was the caregiver of younger children who were unable to complete the questionnaire in the
clinic because they were busy taking care of the younger child during the clinic visit. In
addition, the study was limited by self report data which can lead to overestimation of factors
(e.g., self-efficacy, self-management) and underestimation of depressive symptoms.
Furthermore, in developing this study it was recognized that the disease specific measure of selfmanagement in the CF population was over 20 years old and had limited use. Therefore this
measure may not have fully captured updated practice recommendations and treatment
guidelines. Generalizability was limited because of the single site data collection and majority
participation from female caregivers.
Summary & Conclusions
This was the first time that the IFMST was used to guide CF research. The IFMST would
provide a consistent framework to guide future studies aimed at identifying factors that influence
self-management behaviors of CF in patients and their caregivers. Overall this study of primarily
female caregivers was described as having high SE, and average knowledge. Deficits were noted
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in the areas of reproductive and genetic knowledge. This group overall felt like their children
with CF was close to perfect health. The children with CF in this study had moderate treatment
complexity and high lung function. This study also found differences between Medicaid and
private insurance groups related to knowledge. There were also significant relationships between
disease severity and CF specific SE and nutritional surveillance as well as general SE and
respiratory surveillance.
How Might This Information Affect Nursing Practice
The results of this study have several implications for nursing practice. Because of the
knowledge gaps identified, clinicians need to continually reinforce caregivers understanding of
the disease and in particular with regards to reproductive and genetics knowledge, although it is
important to note that knowledge alone is not sufficient to improve self-management. Selfmanagement plays an important role in successful care of chronic diseases including CF and it is
critical to expand the understanding of what possible factors help predict or drive selfmanagement so that appropriate interventions can be implemented It is also critical to continue to
create tools that are relevant, reliable and valid to assist in the measurement of self-management.
Additionally results from this study can help guide future research in CF as well as other rare
diseases. For the first time ever the number of adult’s with CF is greater than the number of
children. Although this is a testament to the hard work of scientist, researchers, clinicians, and
patients it can pose potential limitations on the number of available participants in the pediatric
clinics. Smaller numbers coupled with competing research studies emphasizes the need for
multiple sites. Additionally, due to space and time constraints in the clinic setting it would be
useful to employ an electronic method of data collection.
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Table 1: Sample Characteristics of Parent/Caregiver

Variables
Contextual Factors
Demographics
Age, y (n=17)
25-35
36-45
46-55
Older than 56
Gender (n=18)
Women

Frequency

5 (31.3)
6 (37.5)
4 (25)
1 (6.3)
17 (94.4)
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Mean (SD)

Range

40.71 (11.06)

25-69

Physical & Social Environment
Ethnicity (n=18)
Non-Hispanic

17 (94.4)

Frequency, %

Hispanic
Race (n=18)
White
Black
Individual & Family Factors
Marital Status (n=15)
Married/Life Partner
Divorced/Separated
Single/Never Married
Relationship to Child with CF (n=16)
Mother
Maternal Grandmother
Father
Education (n=16)
≤ High School
Completed High School
Started College/Tech School
Completed College
Completed Graduate School
Employment Status (n=14)
Full time
Part time
Out of work > 1 year
Homemaker
Retired
Other Children (n=16)
Yes
No
Number of Other Children (n= 13)
1
2
3

Mean (SD)

1 (5.6)
16 (88.9)
2 (11.1)

12 (80)
2 (13.3)
1 (6.7)
14 (87.5)
1 (6.3)
1 (6.3)
1 (6.3)
1 (6.3)
1 (6.3)
11 (68.8)
2 (12.5)
5 (35.7)
3 (21.4)
1 (7.1)
4 (28.6)
1 (7.1)
14 (87.5)
2 (12.5)
6 (46.2)
5 (16.7)
2 (15.4)

Table 2: Child Characteristics
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Range

Height, cm (n=19)
Weight , kg
BMI %
Gender
Males

131.09 (23.64)
77-163.6
33.17 (13.76) 11.05-58.50
49.83 (26.67) 3.46-96.75

15 (60%)

Treatment Complexity
FEV1 (n=16)
FEV1 % Predicted
FEV1 Classification
 Mild
 Moderate
 Severe

12.95 (3.78)

5-12

98.37 (15.83)

66-120

9.85 (4.42)

1-16

14 (87.5)
2 (12.5
0

Age
Years Diagnosed
 0-5
 6-10
 11-15
 < 16

4 (23.5)
4 (23.5)
8 (47)
1 (6)

Other Health Problems
 Yes
 No

5 (29.4)
12 (70.6)

Insurance (n= 19)
Private Insurance
Medicaid

14 (73.7)
5 (26.3)
N

Mean (SD)

Table 3: Descriptive Statistics of Model Variables for Parent/Caregiver
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Range

Context
Condition-Specific
Disease Severity
 Perception

N=18

8.04 (1.45)

4.5-9.9

N=18

2.76 (3.78)

0-12

70.64 (15.32)
65.70 (21.1)
81.48 (12.65)
60.5 (23.26)

39.3-96.4
14.3-87.5
58.3-100
11.1-100

34.28 (2.85)
163.89 (16.81)

31-39
122-180

N=18

77.62 (30.25)

0-100

N=10

87.19 (11.47)

65.5-100

N=17

72.65 (31.27)

7.4-100

N= 14
N=17

82.16 (20.92)
82.55 (17.78)

50-100
34.4-100

Individual and Family
Depressive Symptoms
Process
Knowledge and Beliefs
Knowledge
 Total
 General
 Lung
 Reproductive

N=17

Self Efficacy
 General
 Disease Specific

N=18

Outcome
Family Self Management
Behaviors
Self Management*
 Respiratory
Surveillance
 Respiratory
Treatment
 Chest Physical and
Respiratory therapy
 Malabsorption
 Nutritional
Surveillance
Insurance

Median

U

*Tool allowed for a “skip pattern” for sections that were N/A

Table 4: Group Comparisons between Medicaid and Private Insurance
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P

General Knowledge

Medicaid
Private

57.1
71.4

U= 9.5

p=.038

Lung/GI Knowledge

Medicaid
Private

71.4
91.6

U=16.5

p=.208

Reproductive/Genetic
Knowledge

Medicaid
Private

44.4
66.7

U=8

p=.019

Total Cystic Fibrosis
Knowledge

Medicaid
Private

53.6
78.6

U=8

p=.026

Cystic Fibrosis Self
Efficacy

Medicaid
Private

152
168

U=32.5

p=1

Perceived Health
Competence Scale

Medicaid
Private

31
33

U=15

p=.110

Respiratory
Surveillance Self
Management
Behaviors

Medicaid
Private

94.4
58.3

U=14

p=.066

Respiratory
Treatment Self
Management
Behaviors

Medicaid
Private

89.1
78.1

U=6.5

p=.389

CPT/RT Self
Management
Behaviors

Medicaid
Private

69
91.5

U=22.5

p=.426

Malabsorption Self
Management
Behaviors

Medicaid
Private

90.7
75.1

U=14

p=.374

Diet Self
Management
Behaviors

Medicaid
Private

88.9
87.5

U=23.5

p=.491

Patient Health
Questionnaire 9

Medicaid
Private

4
1

U=26

p=.656
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Table 5: Correlations between Context and Process Variables and Self Management Behaviors
Context:
Respiratory
Treatment
.476
.174
9
-.421
.209
17
.129
.732
10

CPT/RT

Malabsorption

Pearson Correlation
Significance
N
Pearson Correlation
Significance
N
Pearson Correlation
Significance
N

Respiratory
Surveillance
.082
.746
18
.377
.123
18
.373
.127
18

.275
.285
17
.008
.977
15
-.008
.975
17

-.185
.590
14
.042
.872
17
-.428
.102
15

Nutritional
Surveillance
-.117
.665
17
-.606**
.008
18
-.061
.815
17

Pearson Correlation
Significance
N
Pearson Correlation
Significance
N
Pearson Correlation
Significance
N
Pearson Correlation
Significance
N
Pearson Correlation
Significance
N
Pearson Correlation
Significance
N

-.243
.437
17
.316
.216
17
-.187
.473
17
.51
.845
17
-.490*
.039
18
.190
.434
19

-.309
.419
9
-.054
.889
9
-.451
.223
9
-.323
.397
9
-.592
.071
10
.117
.748
10

-.004
.988
16
.602*
.014
16
.285
-.85
16
.337
.202
16
-.093
.723
17
.311
.208
18

-.254
.402
13
-.490
.875
13
.460
.881
13
-.067
.828
13
.365
.200
14
.637*
.011
15

-.172
.525
16
.286
.282
16
.220
.936
16
.055
.839
16
-.070
.788
17
.662**
.003
18

Outcomes:


Treatment Complexity



Perceived Disease
Severity



Depression

Process:
 General Knowledge


Lung/GI Knowledge



Genetic/Reproductive
Knowledge



Total Knowledge



General SE



CF Specific SE

Note: N ≥18 reflected a skip pattern on the self management behavior tool
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Chapter 5
DISCUSSION OF FINDINGS
The purpose of this study was to explore context, process, and outcomes using the
IFSMT as a guide. The findings were presented in detail in Chapter 4.This chapter will address
the limitations of the research, implications for practice, theory, and future research.
Limitations
There are several limitations in the study, notably the small sample size. In additional the
study was limited by self report data which can lead to overestimation of factors (self efficacy,
self management) and underestimation of depression. Generalizability was also limited because
of the single site data collection and majority participation from females.
Recruitment was affected by a number of factors including competing research projects
in the clinic, nature of multi-disciplinary clinics, space limitations and lack of additional sites for
enrollment. Over the one year data collection period there were several other research
opportunities occurring at the same time. One study in particular required a pretest, a 30 minute
educational session and a posttest the following clinic visit. This greatly impacted the ability for
possible participants to participate in an additional study for a 6 month time frame. Additionally
the clinic participates in multiple other research studies, including clinical trials, as well as
quality improvement projects that limited the ability to participate. Attempts were made to
provide additional options for participation including an option to return the surveys by mail.
Participants were given a prepaid self addressed envelope to return the surveys. Unfortunately,
although this worked for some participants, there were an additional 12 participants, including 3
male participants, which consented but failed to return the surveys.
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One other area that posed a problem was the number of providers who needed to see each
patient during a clinic visit. The clinic where data collection took place was a multi- disciplinary
clinic. The clinical team included pulmonary physicians (including fellows, residents, and
medical students), endocrine physicians, respiratory therapy, nutrition, social work, pharmacy,
psychology, research staff, and nursing. During the pre clinic meeting each individual with CF
was discussed and it was noted which team members needed to which person. It was not
uncommon for up to 6-10 people to need to meet with the individual and their family.
Space in the clinic was an additional challenge. Due to infection control requirements,
there are specific rooms in the clinic designated to the CF clinic. The CF clinic has 5 negative
pressure rooms that allow for back to back CF individuals without a “washout” time. When these
rooms were full then other space in the clinic could be used but required a specified time frame
between patients. Essentially in the 1-2 hour appointment all of the various specialties were
trying to get in to see the individual and family. There was a consult room that was available,
however after a several hour appointment the patients and families were ready to leave clinic to
return to their daily activities.
The original proposal included a second site for data collection. Bon Secours Hospital
(St. Mary’s Campus) had a small CF clinic which treated 10-20 eligible individuals. However,
due to the unexpected retirement, and subsequent departure of an additional pulmonary
physician, the site was no longer available for data collection. This was unfortunate because
unlike the primary site this site had limited to no research and fewer barriers with regards to time
and space.
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Implications for Nursing Practice
The results of this study have several implications for nursing practice. Because
of the knowledge gaps identified, clinicians need to continually reinforce caregivers
understanding of the disease and in particular with regards to reproductive and genetics
knowledge, although it is important to note that knowledge alone is not sufficient to improve
self-management. Self-management plays an important role in successful care of chronic
diseases including CF and it is critical to expand the understanding of what possible factors help
predict or drive self-management so that appropriate interventions can be implemented It is also
critical to continue to create tools that are relevant, reliable and valid to assist in the
measurement of self-management. Additionally results from this study can help guide future
research in CF as well as other rare diseases. For the first time ever the number of adult’s with
CF is greater than the number of children. Although this is a testament to the hard work of
scientist, researchers, clinicians, and patients it can pose potential limitations on the number of
available participants in the pediatric clinics. Smaller numbers coupled with competing research
studies emphasizes the need for multiple sites. Additionally, due to space and time constraints in
the clinic setting it would be useful to employ an electronic method of data collection.
Implications for Nursing Theory and Research
This study was the first time the IFMST was used to examine the CF population. The
results provided evidence that the theory provides an organized method to examining factors that
relate to self-management behaviors. More research with larger samples and multiple sites are
needed to further explore the role of the IFMST in the CF population. Future studies using the
IFMST in families should consider family structure and functioning to better understand this
factor.
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Summary
Over the past 20 years little research has been conducted on factors related to self
management in the CF populations. Additional those studies that have explored factors have
been intervention focused without first adequately describing the baseline factor. This was the
first time that the IFMST was used to guide CF research. The IFMST would provide a consistent
framework to guide future studies aimed at identifying factors that influence self-management
behaviors of CF in patients and their caregivers. Overall this study of primarily female caregivers
was described as having high SE, and average knowledge. Deficits were noted in the areas of
reproductive and genetic knowledge. This group overall felt like their children with CF was close
to perfect health. The children with CF in this study had moderate treatment complexity and high
lung function. This study also found differences between Medicaid and private insurance groups
related to knowledge. There were also significant relationships between disease severity and CF
specific SE and nutritional surveillance as well as general SE and respiratory surveillance.
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DEMOGRAPHIC QUESTIONAIRE

These questions are about YOU—not your child. Please read carefully and mark your
response(s).

1. What is your current age? ______
2. What is your gender?
Male
Female
3. What is your ethnicity?
Hispanic or Latino
Not Hispanic or Latino
4. What is your race?
American Indian or Alaska Native

Hawaiian or Other Pacific Islander

Asian

Black or African American

White

5. What is your highest educational level?
Some grammar school completed. What grade?________
Did not complete high school
Completed high school
Started college or technical school
Completed technical school
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Completed college
Started graduate school (master’s or doctoral degree)
Completed graduate school
6. What is your employment status? Check all that apply.
Employed full-time for wages
Employed part-time for wages
Out of work for more than 1 year
Out of work for less than 1 year
A homemaker
Retired

A student
Unable to work; receiving disability

7. What is your marital status?
Married/ Life partner

Divorced/Separated

Single, never been married

other: ________________

Widowed

8. What is your relationship to the child with CF?
Mother

Maternal Grandmother

Maternal Grandfather

Father

Paternal Grandmother

Paternal Grandfather

Other (please list) : ________________

9. In addition to your child with CF do you have other biological children?
Yes
No
If yes, please list ages : ____________________________________________________
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10. In addition to your child with CF do you have other non-biological children?
Yes
No

If yes, please list ages : ____________________________________________________

The following questions are about your child with CF
11. What is the age of your child with Cystic Fibrosis? _______

12. How many years has your child been diagnosed with Cystic Fibrosis? ______

13. Has your child ever been treated in another CF center?
Yes
No

14. Does your child have any other health problems (either related to or not related to CF)?
Yes
No
If yes, please list:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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TREATMENT COMPLEXITY SCORE
TCS Score= 1 point

TCS Score= 2 points

TCS Score = 3 points

Inhaled bronchodilator

Hypertonic saline

Oral bronchodilator

N-acetyl cysteine
(Mucomyst)

Inhaled corticosteroid
Oral corticosteroid

Pancreatic enzymes
Inhaled TOBI (once
per day)
Inhaled other
aminoglycoside
(once per day)

Oxygen
Enteral supplement

Inhaled colistin (once
per day)

Inhaled TOBI (twice per
day)

High dose ibuprofen

Leukotriene
inhibitor/antagonist

Airway clearance
technique
CPAP/BIPAP

Cromolyn/mast cell
stabilizer

Parenteral supplement

Other inhaled chronic Inhaled other
suppressive antibiotic aminoglycoside (twice per
day)
Gastric acid suppressors Dornase alfa
Inhaled colistin (twice
daily)
Oral supplement
CFTR modulators
Insulin
Ursodiol
Cayston
Vitamins
Oral quinolone
Oral azithromycin
(three times weekly)
Other oral antibiotics
Antidepressants
Anxiolytics
Contraceptive/hormonal
methods
Oral hypoglycemic
Pain medication
(chronic)
Diuretic
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Visual Analog Scale
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VISUAL ANALOG SCALE

Please draw a line (I) on how you feel about your child’s current health.

Death

Perfect Health
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APPENDIX D
The Patient Health Questionnaire (Phq-9)
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THE PATIENT HEALTH QUESTIONAIRE (PHQ-9)
Over the past 2 weeks, how often have you been
bothered by any of the following problems?

Not at
All

Several
Days

Nearly
Every Day

1

More
Than
Half the
Days
2

1. Little interest or pleasure in doing things

0

2. Feeling down, depressed or hopeless

0

1

2

3

3. Trouble falling asleep, staying asleep, or
sleeping
too much

0

1

2

3

4. Feeling tired or having little energy

0

1

3

3

5. Poor appetite or overeating

0

1

2

3

6. Feeling bad about yourself- or that you’re
a
failure or have let yourself or your family
down

0

1

2

3

7. Trouble concentrating on things, such as
reading
the newspaper or watching television

0

1

2

3

8. Moving or speaking so slowly that other
people
could have noticed. Or the opposite-being
so
fidgety or restless that you have been
moving
around a lot more than usual

0

1

2

3

9. Thoughts that you would be better off
dead or of hurting yourself in some way

0

1

2

3

85

3

APPENDIX E
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PERCEIVED HEALTH COMPETENCE SCALE

1.

I handle myself well with respect to my (child’s) health

1
Strongly Disagree

2.

4
Agree

5
Strongly Agree

2
Disagree

3
Neutral

4
Agree

5
Strongly Agree

2
Disagree

3
Neutral

4
Agree

5
Strongly Agree

2
Disagree

3
Neutral

4
Agree

5
Strongly Agree

2
Disagree

3
Neutral

4
Agree

5
Strongly Agree

4
Agree

5
Strongly Agree

Typically, my plans for my (child’s) health don’t work out well.

1
Strongly Disagree

8.

3
Neutral

I find my efforts to change things I don’t like about my (child’s) health are ineffective.

1
Strongly Disagree

7.

2
Disagree

I am generally able to accomplish my goals with respect to (my child’s) health.

1
Strongly Disagree

6.

5
Strongly Agree

I succeed in the projects I undertake to improve my (child’s) health.

1
Strongly Disagree

5.

4
Agree

It is difficult for me to find effective solutions to the health problems that come my (child’s) way.

1
Strongly Disagree

4.

3
Neutral

No matter how hard I try, my (child’s) health just doesn’t turn out the way I would like.

1
Strongly Disagree

3.

2
Disagree

2
Disagree

3
Neutral

I am able to do things for my (child’s) health as well as most other people.

1
Strongly Disagree

2
Disagree

3
Neutral
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4
Agree

5
Strongly Agree
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Mountian West Cystic Fibrosis Consortium Questionnaire
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Mountain West Cystic Fibrosis Consortium Questionnaire
Important: the daily care for a child with CF involves many different tasks. Parents must oversee, or manage, these tasks to make sure
they are done as prescribed. We would like to know how confident you feel in managing certain areas of your child’s CF care.
Managing your child’s CF treatments, foods, or mediation does NOT mean that you personally do every treatment or give
every medication. A manager may assign extended family, daycare, babysitters, school or even the child with CF some of the
task necessary for CF care.
For each of the following questions, please circle the number that describes your confidence that you can managed the task
described on a regular basis at the present time.

1. How confident are you that you can correctly perform all the tasks and activities to manage your child’s CF care?

1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

2. How confident are you that you can tell when your child with CF needs to be seen for a sick visit to the CF clinic or doctor’s
office before a problem becomes an emergency?

1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident
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8

9

10
Completely
confident

3. How confident are you that you can manage your child’s CF at home in such a way that your child does not need to go as often
to the CF clinic, doctor’s office, or emergency room for sick visits?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

4. How confident are you that you can correctly manage the respiratory treatments that have been prescribed for your child with
CF?

1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

5. How confident are you that you can manage any inhaled medications (such as Pulmozyme or Tobi) that have been prescribed
for your child with CF?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

6. How confident are you that you can manage any oral medications (such as enzymes or antibiotics) for your child with CF?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident
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8

9

10
Completely
confident

7. How confident are you that you can manage the vitamin supplements prescribed for your child?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

8. How confident are you that you could manage tube feedings for your child with CF if they were prescribed?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

9. Having a child with a chronic illness can cause emotional distress within a family. How confident are you that you can manage
your child’s CF in such a way that emotional distress does not affect your everyday life?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

10. How confident are you that you can manage the weight gain for your child with CF to achieve the best growth possible?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident
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8

9

10
Completely
confident

11. How confident are you that you understand the weight gain and calorie intake goals recommended by your child’s CF center?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

12. How confident are you that you can manage the special diet required for your child with CF?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

13. How confident are you that you can manage the diet or nutritional needs for other family members as well as for those for the
child with CF?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

14. How confident are you that you are able to manage any feeding, eating or mealtime behavior issues for your child with CF?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident
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8

9

10
Completely
confident

15. How confident are you that taking your child to CF center visits at least every three months helps your child, even when your
child is doing well?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

16. How confident are you that your CF center has provided you with best information available to help your child with CF?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

17. Overall, how confident are you that if you do all the treatments, medication and recommendations from the CF center, your
child with CF will live a longer, healthier life?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident

8

9

10
Completely
confident

18. Overall, how confident are you that you are able to follow all the recommendations from the CF center?
1
Not at all
confident

2

3

4
Slightly
confident

5

6

7
Quite
confident
91

8

9

10
Completely
confident
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CF KNOWLEDGE AND ATTIDTUDES QUESTIONNAIRE
CF Knowledge- General Knowledge and complications
1. What is the basic problem in the body that causes symptoms of CF?
The body has severe allergies to food and particles in the air
The body has a weak immune system
The cells in the body cannot properly regulate salt
Several organs in the body are underdeveloped
I’m not sure
2. Do people with CF sweat more, less, or the same amount as people without CF?
More
The same amount
Less
I’m not sure
3. Do people with CF have more, less, or the same amount of salt in their sweat as people
without CF?
More
The same amount
Less
I’m not sure
4. Do people with CF have higher, lower, or the same chance of developing diabetes as
people without CF?
Higher
The same
Lower
I’m not sure
5. Do people with CF have higher, lower, or the same change of developing liver disease
as people without CF?
Higher
The same
Lower
I’m not sure
6. Some people with CF develop kidney disease. What is the common reason for this?
A buildup of mucus in the kidneys causes damage
Some medications prescribed to treat CF can damage the kidneys
Excess salt in the body can damage the kidneys
Infection in the lungs can spread to the kidneys and damage them
I’m not sure
7. Can bone fractures be associated with CF?
Yes
No
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I’m not sure
CF Knowledge- Lung and GI topics
8. Why do people with CF often have more lung infections that people without CF?
People with CF have more allergies than people without CF
People with CF have weak immune systems that cannot fight infection
People with CF have mucus in their lungs that easily traps bacteria
People with CF have malformed or underdeveloped lungs
I’m not sure
9. Does every person with two CF gene mutations develop lung problems?
Yes
No
I’m not sure
10. Should people with CF who have a persistent cough stay at home from work or school
to avoid infecting their peers?
Yes
No
I’m not sure
11. When is physiotherapy (to clear the lungs of mucus recommended)
Only when a person with CF is feeling sick
Only when a person with CF is feeling well
All the time, regardless of whether a person with CF is sick or well
I’m not sure
12. Are people with CF discouraged from exercising and participating in a sport because it
might make them cough?
Yes
No
I’m not sure
13. Does every person with two CF gene mutations develop gastrointestinal (involving the
stomach and intestines) problems?
Yes
No
I’m not sure

104

14. Which organ (often affected by CF) produces and releases defective enzymes?
The pancreas
The stomach
The kidney
The intestine
I’m not sure
15. During digestion, what is the MAIN nutrient that people with CF have trouble
absorbing?
Salt
Calcium
Fat
Iron
I’m not sure
16. What meal below requires more enzymes than any other to help with digesting food?
Chicken sandwich
Lasagna and chips
Roast chicken, boiled potatoes, and vegetables
Chips and gummy candy
I’m not sure
17. Which of the following is a sign of food malabsorption (when the body has trouble
digesting food)? (Check all the apply)
Increased lung infections
Excess coughing
Greasy stools
Clubbing of the fingers
Abdominal pain
Bloating/swelling of the abdomen
Nasal polyps
I’m not sure
CF Knowledge- Reproduction and genetics
18. Does CF affect male fertility?
Yes, most males with CF are infertile
Yes, some males with CF have reduced fertility
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No, it does not affect male fertility at all
I’m not sure

19. Does CF affect female fertility?
Yes, most females with CF are infertile
Yes, some females with CF have reduced fertility
No, it does not affect female fertility at all
I’m not sure
20. Is contraception (to prevent pregnancy) necessary for females with CF who do not wish
to have children?
Yes
No
I’m not sure
21. Does a CF carrier always pass the CF gene mutation on to all of his/her children?
Yes
No
I’m not sure
22. If both parents are carriers of CF, what is the chance of having a child who has CF?
0 (0%)
1 in 2 (50%)
1 in 4 (25%)
1 in 10 (10%)
1 in 100 (1%)
The child will definitely have CF (100%)
I’m not sure
23. IF both parents are carriers of CF, what is the chance of having a child who is neither
affected nor a carrier?
0 (0%)
1 in 2 (50%)
1 in 4 (25%)
1 in 10 (10%)
1 in 100 (1%)
The child will definitely not be affected nor be a CF carrier
I’m not surE
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24. If both parents are carriers of CF, what is the chance of having a child who is a carrier?
0 (0%)
1 in 2 (50%)
1 in 4 (25%)
1 in 10 (10%)
1 in 100 (1%)
The child will definitely be a CF carrier (100%)
I’m not sure
25. If one parent has CF and the other is a carrier for CF, what is the chance of having a
child who has CF?
0 (0%)
1 in 2 (50%)
1 in 4 (25%)
1 in 10 (10%)
1 in 100 (1%)
The child will definitely have CF (100%)
I’m not sure
26. Approximately how many people in America carry one CF gene mutation (what is the
carrier frequency?)
1 in 10
1 in 30
1 in 50
1 in 100
I’m not sure
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RESEARCH SUBJECT INFORMATION AND CONSENT FORM
TITLE: Influence of Contextual Factors and Self Efficacy on Self Management in Parents of
Children with Cystic Fibrosis
VCU IRB NO.: HM20004830
If any information contained in this consent form is not clear, please ask the study staff to
explain any information that you do not fully understand. You may take home an unsigned copy
of this consent form to think about or discuss with family or friends before making your
decision.
PURPOSE OF THE STUDY
The purpose of this research study is to find out about your general knowledge of Cystic
Fibrosis, confidence in handling your child’s health needs, ability to manage their care, and the
complexity of the medications and treatment they need.
You are being asked to participate in this study because you have a child that has Cystic Fibrosis
(CF).
DESCRIPTION OF THE STUDY AND YOUR [YOUR CHILD’S] INVOLVEMENT
If you decide to be in this research study, you will be asked to sign this consent form after you
have had all your questions answered and understand what will happen to you.
Participation in this study is a one time commitment. In this study you will be asked to complete
a series of questionnaires. Completing the questionnaires will take approximately 20-25 minutes.
After you complete the questionnaires, your child’s medical record will be reviewed to obtain
information about medications and treatments they are taking and results of their pulmonary
function test (PFT’s) if available.
RISKS AND DISCOMFORTS
Sometimes people get upset about the time that it will take you to complete the survey. We
anticipate that it will take 20-25 minutes and you will be able to take breaks as necessary.
USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION
103

Authority to Request Protected Health Information

The following people and/or groups may request my Protected Health Information:
 Principal Investigator and Research Staff
 Study Sponsor
 Research Collaborators
 Institutional Review Boards
 Data Safety Monitoring Boards
 Government/Health Agencies
 Others as Required by Law
Authority to Release Protected Health Information
The VCU Health System (VCUHS) may release the information identified in this authorization
from my medical records and provide this information to:
 Health Care Providers at the VCUHS
 Principal Investigator and Research Staff
 Study Sponsor
 Research Collaborators
 Data Coordinators
 Institutional Review Boards
 Data Safety Monitoring Boards
 Government/Health Agencies
 Others as Required by Law
Once your health information has been disclosed to anyone outside of this study, the information
may no longer be protected under this authorization.
Type of Information that may be Released
The following types of information may be used for the conduct of this research:
Complete health record

Diagnosis & treatment
codes

Discharge summary

History and physical exam

Consultation reports

Progress notes

Laboratory test results

X-ray reports

X-ray films / images

Photographs, videotapes

Complete billing record

Itemized bill

Information about drug or alcohol abuse
Information about psychiatric care

Information about Hepatitis B or C tests
Information about sexually transmitted
diseases

Other (specify):

Expiration of This Authorization
This authorization will expire when the research study is closed, or there is no need to review,
analyze and consider the data generated by the research project, whichever is later.
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This research study involves the use of a Data or Tissue Repository (bank) and will never
expire.
Other (specify):
Right to Revoke Authorization and Re-disclosure
You may change your mind and revoke (take back) the right to use your protected health
information at any time. Even if you revoke this Authorization, the researchers may still use or
disclose health information they have already collected about you for this study. If you revoke
this Authorization you may no longer be allowed to participate in the research study. To revoke
this Authorization, you must write to the Principal Investigator.
BENEFITS TO YOU AND OTHERS
You may not get any direct benefit from this study, but, the information we learn from people in
this study may help us design better programs to support families who have children with CF.
COSTS
There are no costs for participating in this study other than the time you will spend filling out the
questionnaires.
Alternatives
Your alternative is not to participate in this study.
CONFIDENTIALITY
Potentially identifiable information about you will consist of questionnaires and information
taken from the medical record. Data is being collected only for research purposes.
Your data will be identified by ID numbers not names, and stored separately from research data
in a locked research area. All personal identifying information will be kept in password protected
files and these files will be deleted after 5 years. Other records such as completed questionnaires
will be kept in a locked file cabinet for 5 years after the study ends and will be destroyed at that
time. Access to all data will be limited to study personnel. A data and safety monitoring plan is
established.
We will not tell anyone the answers you give us; however, information from the study and
information from your child’s medical record and the consent form signed by you may be looked
at or copied for research or legal purposes, or by Virginia Commonwealth University. Personal
information about you might be shared with or copied by authorized officials of the Department
of Health and Human Services or other federal regulatory bodies.
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What we find from this study may be presented at meetings or published in papers, but your
name will not ever be used in these presentations or papers.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
You do not have to participate in this study. If you choose to participate, you may stop at any
time without any penalty. You may also choose not to answer particular questions that are asked
in the study.

Should you decide you wish to withdraw your date you can notify the PI or student investigator
by either written or oral communication.
Your participation in this study may be stopped at any time by the study staff without your
consent. The reasons might include:





the study staff thinks it necessary for your health or safety;
you have not followed study instructions;
the sponsor has stopped the study; or
administrative reasons require your withdrawal.

QUESTIONS
If you have any questions, complaints, or concerns about your participation in this research,
contact:
Jeanne Salyer Ph.D., RN
School of Nursing
Virginia Commonwealth University
1100 East Leigh Street
Richmond, VA 23239
Telephone: (804) 828-2773
Erin Booth, MS, RN
Telephone: (804) 516-4925
The researchers/study staff named above are the best person(s) to call for questions about your
participation in this study.
If you have any general questions about your rights as a participant in this or any other research,
you may contact:
Office of Research
Virginia Commonwealth University
800 East Leigh Street, Suite 3000
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P.O. Box 980568
Richmond, VA 23298
Telephone: (804) 827-2157
Contact this number to ask general questions, to obtain information or offer input, and to express
concerns or complaints about research. You may also call this number if you cannot reach the
research team or if you wish to talk with someone else. General information about participation
in research studies can also be found at http://www.research.vcu.edu/irb/volunteers.htm.

CONSENT
I have been given the chance to read this consent form. I understand the information about this
study. Questions that I wanted to ask about the study have been answered. My signature says
that I am willing to participate in this study. I will receive a copy of the consent form once I
have agreed to participate.

Participant name printed

Participant signature

Date

________________________________________________
Name of Person Conducting Informed Consent
Discussion / Witness
(Printed)

________________________________________________ ________________
Signature of Person Conducting Informed Consent
Discussion / Witness
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Date

________________________________________________ ________________
Principal Investigator Signature (if different from above)
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Date

VITA

Erin Booth was born on September 15, 1982, in Richmond, Virginia. She graduated from
James River High School, Midlothian, Virginia in 2000 and received her Bachelor of Science in
Nursing from East Carolina University, Greenville, North Carolina in 2004. In 2008 she received
her Master of Science from Virginia Commonwealth University with a focus in Leadership and
Administration. Throughout her career she has been employed in a variety of settings including
inpatient, outpatient, and pharmacy care of individuals with Cystic Fibrosis.
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